{"content":"<li class=\"n-box-item date-title\" data-end=\"1508471999\" data-start=\"1508385600\" data-txt=\"Monday, December 23, 2019\">Thursday, October 19, 2017</li><li class=\"n-box-item sa-box-item\" data-id=\"3302494\" data-ts=\"1508456470\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BIDU\" target=\"_blank\">BIDU</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3302494-baidu-in-deals-baic-king-long-to-speed-autonomous-vehicle-lines\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Baidu in deals with BAIC, King Long to speed autonomous vehicle lines</a></h4><ul>   <li>Baidu (<a href=\"http://seekingalpha.com/symbol/BIDU\" target=\"_blank\">BIDU</a> <font color='red'>-1.7%</font>) has <a href=\"https://seekingalpha.com/pr/16974633-baidu-signs-strategic-partnership-agreements-baic-group-king-long-accelerate-autonomous\" target=\"_blank\">signed strategic partnerships</a> with BAIC Group and King Long in a move to speed up its autonomous driving project.</li>    <li>With BAIC Group, one of China's biggest automakers, Baidu will work to mass-produce vehicles with \"Level 3\" autonomous features around 2019, and fully autonomous Level 4 cars around 2021.</li>    <li>Meanwhile, the work with King Long will involve putting autonomous buses running on designated routes into mass production and trials by the end of next year.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3302494\" data-linked=\"Baidu in deals with BAIC, King Long to speed autonomous vehicle lines\" data-tweet=\"$BIDU - Baidu in deals with BAIC, King Long to speed autonomous vehicle lines https://seekingalpha.com/news/3302494-baidu-in-deals-baic-king-long-to-speed-autonomous-vehicle-lines?source=tweet\" data-url=\"https://seekingalpha.com/news/3302494-baidu-in-deals-baic-king-long-to-speed-autonomous-vehicle-lines\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:41 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>6&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3302486\" data-ts=\"1508450459\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CBS\" target=\"_blank\">CBS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3302486-cbs-launches-exchange-offer-for-radio-spin-off\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">CBS launches exchange offer for radio spin-off</a></h4><ul>   <li>CBS (<a href=\"http://seekingalpha.com/symbol/CBS\" target=\"_blank\">CBS</a> <font color='green'>+1.5%</font>) has <a href=\"https://seekingalpha.com/pr/16974388-cbs-corporation-launches-exchange-offer-split-cbs-radio\" target=\"_blank\">launched an exchange offer</a> as part of the separation of its radio business, which it set to combine with Entercom (<a href=\"http://seekingalpha.com/symbol/ETM\" target=\"_blank\">ETM</a> <font color='red'>-3.8%</font>).</li>    <li>CBS had elected to go with a \"reverse Morris Trust\" transaction to keep the spin-off tax-free for shareholders.</li>    <li>The offer allows for CBS shareholders to exchange Class B common stock for shares of CBS Radio common stock, which will immediately be converted into the right to get an equal number of shares of Entercom at the merger's closing.</li>    <li>The exchange will come at a 7% discount, subject to an upper limit, which means that tendering shareholders will get about $1.08 of CBS Radio stock for each $1.00 of CBS Class B stock tendered and accepted.</li>    <li>The offer will expire on Nov. 16.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3302486\" data-linked=\"CBS launches exchange offer for radio spin-off\" data-tweet=\"$CBS $VIAC $ETM - CBS launches exchange offer for radio spin-off https://seekingalpha.com/news/3302486-cbs-launches-exchange-offer-for-radio-spin-off?source=tweet\" data-url=\"https://seekingalpha.com/news/3302486-cbs-launches-exchange-offer-for-radio-spin-off\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  6:00 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>5&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3302480\" data-ts=\"1508449331\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AAXN\" target=\"_blank\">AAXN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3302480-axon-says-sec-is-reviewing-financial-reports\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Axon says SEC is reviewing its financial reports</a></h4><ul>     <li>Axon Enterprise (NASDAQ:<a href='https://seekingalpha.com/symbol/AAXN' title='Axon Enterprise, Inc.'>AAXN</a>)&nbsp;<font color='red'>-4.1%</font> after-hours after disclosing that the SEC was <a href=\"https://seekingalpha.com/filing/3732514\" target=\"_blank\">reviewing its financial reports</a> for FY 2016 and the March 2017 quarter, but offers no further information.</li>     <li>&ldquo;The company is in the process of providing the SEC with information responsive to their comments and intends to respond to the SEC within the next seven days,&rdquo; AAXN says in the filing.</li></ul><div class=\"tiny-share-widget\" data-id=\"3302480\" data-linked=\"Axon says SEC is reviewing its financial reports\" data-tweet=\"$AAXN - Axon says SEC is reviewing its financial reports https://seekingalpha.com/news/3302480-axon-says-sec-is-reviewing-financial-reports?source=tweet\" data-url=\"https://seekingalpha.com/news/3302480-axon-says-sec-is-reviewing-financial-reports\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:42 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>21&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3302479\" data-ts=\"1508448908\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NCR\" target=\"_blank\">NCR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3302479-ncr-reports-q3-lowers-guidance-to-miss-estimates-sharesminus-10_93\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">NCR reports Q3, lowers guidance to miss estimates; shares -10.93%</a></h4><ul><li>        NCR (NYSE:<a href='https://seekingalpha.com/symbol/NCR' title='NCR Corporation'>NCR</a>) shares are&nbsp;<font color='red'>down 10.93%</font>&nbsp;aftermarket following Q3 results that beat EPS but missed revenue estimates. The company lowers its FY17 guidance due to lower than anticipated ATM revenue and both full year and Q4 guidance come in below consensus.</li><li>               Q4 guidance: revenue, $1.74B to $1.79B (consensus: $1.92B); EPS, $0.83 to $0.93 (consensus: $1.10).&nbsp;&nbsp;</li><li>        FY17 guidance: revenue, $6.475B to $6.525B (consensus: $6.67B); EPS, $3.10 to $3.20 (consensus: $3.36); cash from operations, $745M to $775M; FCF, $440M to $470M.&nbsp;</li><li>               Segment revenue: software license, $79M (-12% Y/Y); software maintenance, $95M (+3%); cloud, $149M (+5%); professional services, $153M (+6%); software revenue, $476M (+2%); services revenue, $609M (+3%); ATM, $273M (-16%); SCO, $79M (-24%); POS, $221M (+19%); IPS, $5M (flat); hardware revenue, $578M (-6%).&nbsp;</li><li>               Key financials: NCR reported non-GAAP gross margin of 29.2%, down slightly on the year due to lower software license sales and lower ATM and SCO volumes. Operating expenses were $251M, down from $261M last year.&nbsp;</li><li>               Cash flow: NCR had $133M in cash from operating activities, down from $225M. FCF was $45M and NCR ended the quarter with $405M in cash and equivalents.&nbsp;</li><li>               <a href=\"https://seekingalpha.com/pr/16974418-ncr-announces-third-quarter-2017-results\" target=\"_blank\">Press release</a>&nbsp;&nbsp;</li></ul><div class=\"tiny-share-widget\" data-id=\"3302479\" data-linked=\"NCR reports Q3, lowers guidance to miss estimates; shares -10.93%\" data-tweet=\"$NCR - NCR reports Q3, lowers guidance to miss estimates; shares -10.93% https://seekingalpha.com/news/3302479-ncr-reports-q3-lowers-guidance-to-miss-estimates-sharesminus-10_93?source=tweet\" data-url=\"https://seekingalpha.com/news/3302479-ncr-reports-q3-lowers-guidance-to-miss-estimates-sharesminus-10_93\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:35 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3302478\" data-ts=\"1508448904\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3302478-after-hours-gainers-losers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">After Hours Gainers / Losers</a></h4><ul>     <li><b>Top gainers, as of 5.25 p.m.:</b> <a href='https://seekingalpha.com/symbol/SKX' title='Skechers USA Inc.'>SKX</a> <font color='green'>+20.7%</font>. <a href='https://seekingalpha.com/symbol/TEAM' title='Atlassian'>TEAM</a> <font color='green'>+11.8%</font>. <a href='https://seekingalpha.com/symbol/CAI' title='CAI International, Inc.'>CAI</a> <font color='green'>+4.8%</font>. <a href='https://seekingalpha.com/symbol/PYPL' title='PayPal Holdings, Inc.'>PYPL</a> <font color='green'>+4.4%</font>. <a href='https://seekingalpha.com/symbol/IMDZ' title='Immune Design'>IMDZ</a> <font color='green'>+3.6%</font>.</li><li><b>Top losers, as of 5.25p.m.:</b> <a href='https://seekingalpha.com/symbol/NCR' title='NCR Corporation'>NCR</a> <font color='red'>-10.9%</font>. <a href='https://seekingalpha.com/symbol/CELG' title='Celgene Corporation'>CELG</a> <font color='red'>-6.7%</font>. <a href='https://seekingalpha.com/symbol/AAXN' title='Axon Enterprise, Inc.'>AAXN</a> <font color='red'>-4.6%</font>. <a href='https://seekingalpha.com/symbol/ATHN' title='athenahealth, Inc.'>ATHN</a> <font color='red'>-3.9%</font>. <a href='https://seekingalpha.com/symbol/ISRG' title='Intuitive Surgical, Inc.'>ISRG</a> <font color='red'>-3.8%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3302478\" data-linked=\"After Hours Gainers / Losers\" data-tweet=\"$SKX $TEAM $CAI - After Hours Gainers / Losers https://seekingalpha.com/news/3302478-after-hours-gainers-losers?source=tweet\" data-url=\"https://seekingalpha.com/news/3302478-after-hours-gainers-losers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:35 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3302465\" data-ts=\"1508447201\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PFPT\" target=\"_blank\">PFPT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3302465-proofpoint-reports-q3-beats-mostly-strong-guidance-through-fy18\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Proofpoint reports Q3 beats, mostly strong guidance through FY18</a></h4><ul><li>        Proofpoint (NASDAQ:<a href='https://seekingalpha.com/symbol/PFPT' title='Proofpoint, Inc.'>PFPT</a>) shares are&nbsp;<font color='red'>down 3.31%</font>&nbsp;aftermarket following Q3 results that beat EPS and revenue estimates. Billings were up 33% on the year to $166.5M.&nbsp;</li><li>               Q4 guidance: revenue, $138M to $140M (consensus: $138.52M); billings, $180M to $182; Non-GAAP gross margin, 77.5%; EPS, $0.19 to $0.21 (consensus: $0.18); FCF, $25M to $27M.&nbsp;</li><li>               FY17 guidance: revenue, $508M to $510M (consensus: $505.96M); billings, $630M to $632M; Non-GAAAP gross margin, 77%; EPS, $0.73 to $0.75 (consensus: $0.65); FCF, $101.5M to $103.5M.&nbsp;</li><li>               FY18 guidance: revenue, $644M to $648M (consensus: $649.12M); billings, $798M to $802M; EPS, $0.96 to $1.03 (consensus: $1.01); FCF, $135M.&nbsp;</li><li>               Key financials: Non-GAAP gross margin was 78%, up one percentage point on the year. Operating expenses were up 36% on the year to $114.4M with $32.5M in R&amp;D spending, $68.5M in sales and marketing, and $13.4M in general and administrative.&nbsp;</li><li>               Cash flow: Proofpoint reported $44.2M in net cash from operations. FCF was $32.3M and the company ended the quarter with $459.6M in cash and equivalents.&nbsp;</li><li>               <a href=\"https://seekingalpha.com/pr/16974386-proofpoint-announces-third-quarter-2017-financial-results\" target=\"_blank\">Press release</a>&nbsp; &nbsp;&nbsp;&nbsp;</li><li>Previously: <a href=\"https://seekingalpha.com/news/3302364-proofpoint-beats-0_07-beats-revenue\" target=\"_blank\">Proofpoint beats by $0.07, beats on revenue</a> (Oct. 19)</li></ul><div class=\"tiny-share-widget\" data-id=\"3302465\" data-linked=\"Proofpoint reports Q3 beats, mostly strong guidance through FY18\" data-tweet=\"$PFPT - Proofpoint reports Q3 beats, mostly strong guidance through FY18 https://seekingalpha.com/news/3302465-proofpoint-reports-q3-beats-mostly-strong-guidance-through-fy18?source=tweet\" data-url=\"https://seekingalpha.com/news/3302465-proofpoint-reports-q3-beats-mostly-strong-guidance-through-fy18\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:06 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3302442\" data-ts=\"1508446148\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CELG\" target=\"_blank\">CELG</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3302442-celgene-hits-bump-in-road-ibd-candidate-gedminus-0301-two-studies-terminated-shares-poised\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Celgene hits bump in road with IBD candidate GED-0301, two studies terminated; shares poised for down move after hours</a></h4><ul><li>Celgene (NASDAQ:<a href='https://seekingalpha.com/symbol/CELG' title='Celgene Corporation'>CELG</a>) has <a href=\"https://seekingalpha.com/pr/16974468-celgene-provides-update-gedminus-0301-mongersen-inflammatory-bowel-disease-program\" target=\"_blank\">pulled the plug</a> on two studies evaluating GED-0301 (mongersen) for the treatment Crohn's disease based on the recommendation from the independent Data Monitoring Committee &#40;DMC&#41;. After reviewing interim data, the DMC determined that the treatment benefit did not sufficiently outweigh the risk. No safety signals were observed, though.</li><li>The two discontinued studies were Phase 3 RESOLVE (CD-002) and the extension trial, SUSTAIN (CD-004).</li><li>The planned Phase 3 DEFINE study (CD-003) in Crohn's will not be initiated.</li><li>The company is waiting to review the data from the Phase 2 study in ulcerative colitis to determine the next steps.</li><li>Mongersen is an oral antisense drug, specifically an oligonucleotide that decreases a protein called Smad7 which is abnormally high in Crohn's disease. Elevated levels of Smad7 interfere with an anti-inflammatory pathway in the gut called TGF-&beta;1 which leads to increased inflammation.</li><li>After-hours trading, currently suspended, will resume at 5:00 pm ET.</li><li><strong>Update</strong>: Shares are down&nbsp;<font color='red'>7%</font>&nbsp;after hours.</li></ul><div class=\"tiny-share-widget\" data-id=\"3302442\" data-linked=\"Celgene hits bump in road with IBD candidate GED-0301, two studies terminated; shares poised for down move after hours\" data-tweet=\"$CELG - Celgene hits bump in road with IBD candidate GED-0301, two studies terminated; shares poised for down move after hours https://seekingalpha.com/news/3302442-celgene-hits-bump-in-road-ibd-candidate-gedminus-0301-two-studies-terminated-shares-poised?source=tweet\" data-url=\"https://seekingalpha.com/news/3302442-celgene-hits-bump-in-road-ibd-candidate-gedminus-0301-two-studies-terminated-shares-poised\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:49 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>64&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3302418\" data-ts=\"1508445416\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MXIM\" target=\"_blank\">MXIM</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3302418-maxim-integrated-reports-mixed-q1-strong-guidance\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Maxim Integrated reports mixed Q1, strong guidance</a></h4><ul><li>        Maxim Integrated Products (NASDAQ:<a href='https://seekingalpha.com/symbol/MXIM' title='Maxim Integrated Products, Inc.'>MXIM</a>) shares are&nbsp;<font color='green'>up 2.22%&nbsp;</font>aftermarket following Q1 results that beat EPS and narrowly missed revenue estimates.</li><li>               Q2 outlook: revenue, $600M to $640M (consensus: $583.9M); gross margin, 66% to 68%; EPS, $0.61 to $0.67 (consensus: $0.57).&nbsp;</li><li>               Key financials: Non-GAAP gross margin was 66.9%. Operating expenses totaled $188.7M, up 9% primarily due to a nearly $3M increase in SG&amp;A spending to $73.7M.&nbsp;</li><li>               Cash flow: Cash flow from operations totaled $220M in the quarter. Gross capital expenditures were $14M and FCF TTM $819M. The company paid out $101M in dividends at $0.36 per share and repurchased $75M in stock.&nbsp;</li><li>               <a href=\"https://seekingalpha.com/pr/16974374-maxim-integrated-reports-results-first-quarter-fiscal-2018\" target=\"_blank\">Press release</a>&nbsp; &nbsp;&nbsp;&nbsp;</li></ul><div class=\"tiny-share-widget\" data-id=\"3302418\" data-linked=\"Maxim Integrated reports mixed Q1, strong guidance\" data-tweet=\"$MXIM - Maxim Integrated reports mixed Q1, strong guidance https://seekingalpha.com/news/3302418-maxim-integrated-reports-mixed-q1-strong-guidance?source=tweet\" data-url=\"https://seekingalpha.com/news/3302418-maxim-integrated-reports-mixed-q1-strong-guidance\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:36 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3302415\" data-ts=\"1508445296\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ENT\" target=\"_blank\">ENT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3302415-global-eagleminus-2_1-after-posting-q4-2016-results\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Global Eagle -2.1% after posting Q4 2016 results</a></h4><ul>   <li>Global Eagle Entertainment (NASDAQ:<a href='https://seekingalpha.com/symbol/ENT' title='Global Eagle Entertainment, Inc.'>ENT</a>) <font color='red'>fell 2.1%</font> after posting some delayed <a href=\"https://seekingalpha.com/news/3302049-global-eagle-entertainment-reports-q4-results\" target=\"_blank\">Q4 results</a> from the last calendar quarter of 2016.</li>    <li>The company had faced delays but in April said a review of its controls found no material weaknesses, and that it didn't expect to restate any numbers.</li>    <li>&ldquo;We have made significant enhancements to our finance department in the last six months as we improve both our processes and controls,&rdquo; says CFO Paul Rainey.</li>    <li>Revenue grew 45.5% Y/Y, mainly due to a summer 2016 acquisition of Emerging Market Communications.</li>    <li>Net loss was $91.7M, affected by a goodwill impairment charge of $64M tied to the Maritime &amp; Land Connectivity business it acquired with EMC. (It expects a further impairment of $75M-$80M for Q1 2017 from the same business.)</li>    <li>EBITDA was $19.4M, beating an expected $18.7M.</li>    <li><a href=\"https://seekingalpha.com/pr/16973056-global-eagle-announces-fourth-quarter-full-year-2016-results\" target=\"_blank\">Press Release</a></li> </ul><div class=\"tiny-share-widget\" data-id=\"3302415\" data-linked=\"Global Eagle -2.1% after posting Q4 2016 results\" data-tweet=\"$ENT - Global Eagle -2.1% after posting Q4 2016 results https://seekingalpha.com/news/3302415-global-eagleminus-2_1-after-posting-q4-2016-results?source=tweet\" data-url=\"https://seekingalpha.com/news/3302415-global-eagleminus-2_1-after-posting-q4-2016-results\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:34 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3302411\" data-ts=\"1508445153\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ISRG\" target=\"_blank\">ISRG</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3302411-intuitive-surgical-q3-revenue-up-7-earnings-up-34-shares-up-4-after-hours\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Intuitive Surgical Q3 revenue up 7%; earnings up 34%; shares up 4% after hours</a></h4><ul><li>Intuitive Surgical (NASDAQ:<a href='https://seekingalpha.com/symbol/ISRG' title='Intuitive Surgical, Inc.'>ISRG</a>) <a href=\"https://seekingalpha.com/pr/16974380-intuitive-surgical-announces-third-quarter-earnings\" target=\"_blank\">Q3 results</a> ($M): Revenue: 806.1 (+6.6%); Systems: 258.1 (+19.3%); Services: 146.8 (+3.4%).</li><li>Net Income: 297.5 (+34.3%); Non-GAAP Net Income: 323.8 (+41.8%); EPS: 2.55 (+32.8%); Non-GAAP EPS: 2.77 (+39.9%).</li><li>Global <em>da Vinci</em> procedures up 15%.</li><li>Total <em>da Vinci</em> shipments: 169 (+26%).</li><li>Shares are up&nbsp;<font color='green'>4%</font>&nbsp;after hours on average volume.</li></ul><div class=\"tiny-share-widget\" data-id=\"3302411\" data-linked=\"Intuitive Surgical Q3 revenue up 7%; earnings up 34%; shares up 4% after hours\" data-tweet=\"$ISRG - Intuitive Surgical Q3 revenue up 7%; earnings up 34%; shares up 4% after hours https://seekingalpha.com/news/3302411-intuitive-surgical-q3-revenue-up-7-earnings-up-34-shares-up-4-after-hours?source=tweet\" data-url=\"https://seekingalpha.com/news/3302411-intuitive-surgical-q3-revenue-up-7-earnings-up-34-shares-up-4-after-hours\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:32 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>8&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3302400\" data-ts=\"1508444897\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PYPL\" target=\"_blank\">PYPL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3302400-paypal-up-3_8-after-topping-estimates\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">PayPal up 3.8% after topping estimates</a></h4><ul><li>Q3 income of $560M or $0.46 per share vs. $425M and $0.35 one year ago. Expectations were for $0.43. Free cash flow of $841M up from $618M.</li><li>Operating margin of 19.9% up 150 basis points Y/Y.</li><li>8.2M user accounts added, with net new actives up 88%. 218M active customer accounts with 17M merchant accounts. Payment transactions up 26% to 1.9B. 32.8 payment transactions per active account on a trailing 12-month basis, up 9%. Total payment volume up 29% (FX neutral) to $114B.</li><li>Full-year EPS seen at $1.86-$1.88, with revenue up 20%-21%. Q4 EPS guided to $0.50-$0.52.</li><li><a href=\"https://investor.paypal-corp.com\" target=\"_blank\">Conference call at 5 ET</a></li><li>Previously: <a href=\"https://seekingalpha.com/news/3302362-paypal-beats-0_03-beats-revenue\" target=\"_blank\">PayPal beats by $0.03, beats on revenue</a> (Oct. 19)</li><li><a href='https://seekingalpha.com/symbol/PYPL' title='PayPal Holdings, Inc.'>PYPL</a>&nbsp;<font color='green'>+3.8%</font>&nbsp;after hours</li></ul><div class=\"tiny-share-widget\" data-id=\"3302400\" data-linked=\"PayPal up 3.8% after topping estimates\" data-tweet=\"$PYPL - PayPal up 3.8% after topping estimates https://seekingalpha.com/news/3302400-paypal-up-3_8-after-topping-estimates?source=tweet\" data-url=\"https://seekingalpha.com/news/3302400-paypal-up-3_8-after-topping-estimates\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:28 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>14&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3302396\" data-ts=\"1508444818\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SKX\" target=\"_blank\">SKX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3302396-skechers-soars-after-jogging-past-profit-estimates\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Skechers soars after jogging past profit estimates</a></h4><ul><li>Shares of Skechers (NYSE:<a href='https://seekingalpha.com/symbol/SKX' title='Skechers USA Inc.'>SKX</a>) soar in after-hours trading after a resounding Q3 profit beat off of broad-based sales leverage.</li><li>A 26% jump in the company's international wholesales business helped lead to a 16% increase in total revenue during the quarter. Management cited strong results out the U.K. and China.</li><li>Gross profit was up 190 bps to 47.5% of sales.</li><li>Skechers guided for Q4 revenue of $860M to $885M.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3302353-skechers-beats-0_15-beats-revenue\" target=\"_blank\">Skechers beats by $0.15, beats on revenue</a> (Oct. 19)</li><li>SKX&nbsp;<font color='green'>+20.27%</font>&nbsp;AH to $28.90, a level not seen since the middle part of August.</li></ul><div class=\"tiny-share-widget\" data-id=\"3302396\" data-linked=\"Skechers soars after jogging past profit estimates\" data-tweet=\"$SKX - Skechers soars after jogging past profit estimates https://seekingalpha.com/news/3302396-skechers-soars-after-jogging-past-profit-estimates?source=tweet\" data-url=\"https://seekingalpha.com/news/3302396-skechers-soars-after-jogging-past-profit-estimates\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:26 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>16&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3302384\" data-ts=\"1508444537\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ATHN\" target=\"_blank\">ATHN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3302384-athenahealth-q3-top-line-up-11-earnings-down-7-operating-income-guidance-raised-shares-down-1\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Athenahealth Q3 top line up 11%; earnings down 7%; operating income guidance raised; shares down 1% after hours</a></h4><ul><li>Athenahealth (NASDAQ:<a href='https://seekingalpha.com/symbol/ATHN' title='athenahealth, Inc.'>ATHN</a>) <a href=\"https://globenewswire.com/news-release/2017/10/19/1150652/0/en/athenahealth-Reports-Third-Quarter-Fiscal-Year-2017-Results.html\" target=\"_blank\">Q3 results</a> ($M): Revenues: 295.8 (+10.7%).</li><li>Net Income: 13.0 (-6.5%); Non-GAAP Net Income: 22.9 (-5.0%); EPS: 0.32 (-8.6%); Non-GAAP EPS: 0.56 (-6.7%); CF Ops (9 mo.): 156.6 (+15.1%).</li><li>Operating Income: 18.6 (+22.4%); Non-GAAP Operating Income: 39.5 (-5.0%).</li><li><strong>2017 Guidance</strong>: Revenues: $1.20B - 1.22B from $1.21B - 1.25B; Operating Income: $29M - 53M from $36M - 46M; Non-GAAP Operating Income: $135M - 150M from $120M - 140M.</li><li>Management reiterates its goal of at least a 15% non-GAAP operating margin in 2018. It is also increasing its pretax cost savings target to $100M - 115M via a new organizational design, marketing program rationalization and real estate optimization including closing offices in San Francisco and Princeton. The organizational redesign includes a 9% workforce reduction.</li><li>Shares are down&nbsp;<font color='red'>1%</font>&nbsp;after hours on light volume.</li></ul><div class=\"tiny-share-widget\" data-id=\"3302384\" data-linked=\"Athenahealth Q3 top line up 11%; earnings down 7%; operating income guidance raised; shares down 1% after hours\" data-tweet=\"$ATHN - Athenahealth Q3 top line up 11%; earnings down 7%; operating income guidance raised; shares down 1% after hours https://seekingalpha.com/news/3302384-athenahealth-q3-top-line-up-11-earnings-down-7-operating-income-guidance-raised-shares-down-1?source=tweet\" data-url=\"https://seekingalpha.com/news/3302384-athenahealth-q3-top-line-up-11-earnings-down-7-operating-income-guidance-raised-shares-down-1\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:22 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3302378\" data-ts=\"1508444389\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CAI\" target=\"_blank\">CAI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3302378-cai-international-beats-0_20-beats-on-revenue\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">CAI International beats by $0.20, beats on revenue</a></h4><ul><li>CAI International (NYSE:<a href='https://seekingalpha.com/symbol/CAI' title='CAI International, Inc.'>CAI</a>): Q3 EPS of $0.90 <font color='green'>beats by $0.20</font>.</li><li>Revenue of $90.2M (+14.9% Y/Y) <font color='green'>beats by $1.2M</font>.</li><li>Shares <font color='green'>+5.2%</font>.</li><li><a href='https://seekingalpha.com/pr/16974318-cai-international-inc-reports-results-third-quarter-2017'>Press Release</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3302378\" data-linked=\"CAI International beats by $0.20, beats on revenue\" data-tweet=\"$CAI - CAI International beats by $0.20, beats on revenue https://seekingalpha.com/news/3302378-cai-international-beats-0_20-beats-on-revenue?source=tweet\" data-url=\"https://seekingalpha.com/news/3302378-cai-international-beats-0_20-beats-on-revenue\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:19 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3302376\" data-ts=\"1508444319\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TACO\" target=\"_blank\">TACO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3302376-comparable-sales-solid-del-taco\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Comparable sales solid at Del Taco</a></h4><ul><li>Del Taco (NASDAQ:<a href='https://seekingalpha.com/symbol/TACO' title='Del Taco Restaurants, Inc.'>TACO</a>) reports systemwide comparable sales growth of 4.1% in Q3, a mark that easily tops recent averages in the restaurant sector.</li><li>Transactions were down 0.3% during the quarter, but that was more than offset by a 4% increase in average check.</li><li>Interestingly, newly-introduced queso tracked at 7% of sales.</li><li>Restaurant contribution margin fell 170 bps to 19.2% of sales as food input costs factored in on top of the painful bite of higher labor expenses.</li><li>Looking ahead, Del Taco expects full-year revenue of $472M to $475M vs, $473M consensus.&nbsp;EPS of $0.52 to $0.54 is anticipated vs. $0.52-$0.55 prior view and $0.56 consensus.</li><li>TACO&nbsp;<font color='red'>-2.86%</font>&nbsp;AH to $14.95.</li></ul><div class=\"tiny-share-widget\" data-id=\"3302376\" data-linked=\"Comparable sales solid at Del Taco\" data-tweet=\"$TACO - Comparable sales solid at Del Taco https://seekingalpha.com/news/3302376-comparable-sales-solid-del-taco?source=tweet\" data-url=\"https://seekingalpha.com/news/3302376-comparable-sales-solid-del-taco\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:18 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3302374\" data-ts=\"1508444268\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ETFC\" target=\"_blank\">ETFC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3302374-e-trademinus-1_6-after-earnings-acquisition\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">E*Trade -1.6% after earnings, acquisition</a></h4><ul><li>Q3 net income of $147M or $0.49 per share negatively by items totaling $16M or $0.06 per share. Adding back in yield Q3 EPS of $0.55 vs. $0.51 a year ago. Expectations were for $0.51.</li><li>Adjusted operating margin of 42% vs. 34% a year ago.</li><li>4.6M shares bought back at average price of $40.64 each; total of $187M.</li><li>Announced is the acquisition of Trust Company of America for $275M in cash. Based in Denver, TCA has about $17B in institutional assets under custody and more than 180 active RIAs on its platform. The deal is seen as neutral to earnings next year and accretive in 2019. It's expected to close in Q2 of 2018.</li><li><a href=\"http://about.etrade.com\" target=\"_blank\">Conference call at 5 ET</a></li><li>Previously: <a href=\"https://seekingalpha.com/news/3302359-e-trade-financial-beats-0_04-revenue-line\" target=\"_blank\">E*TRADE Financial beats by $0.04,  revenue in-line</a> (Oct. 19)</li><li><a href='https://seekingalpha.com/symbol/ETFC' title='E*TRADE Financial Corporation'>ETFC</a>&nbsp;<font color='red'>-1.6%</font>&nbsp;after hours</li></ul><div class=\"tiny-share-widget\" data-id=\"3302374\" data-linked=\"E*Trade -1.6% after earnings, acquisition\" data-tweet=\"$ETFC - E*Trade -1.6% after earnings, acquisition https://seekingalpha.com/news/3302374-e-trademinus-1_6-after-earnings-acquisition?source=tweet\" data-url=\"https://seekingalpha.com/news/3302374-e-trademinus-1_6-after-earnings-acquisition\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:17 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3302362\" data-ts=\"1508443906\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PYPL\" target=\"_blank\">PYPL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3302362-paypal-beats-0_03-beats-on-revenue\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">PayPal beats by $0.03, beats on revenue</a></h4><ul><li>PayPal (NASDAQ:<a href='https://seekingalpha.com/symbol/PYPL' title='PayPal Holdings, Inc.'>PYPL</a>): Q3 EPS of $0.46 <font color='green'>beats by $0.03</font>.</li><li>Revenue of $3.24B (+21.3% Y/Y) <font color='green'>beats by $60M</font>.</li><li>Shares <font color='green'>+2.5%</font>.</li><li><a href='https://seekingalpha.com/pr/16974392-paypal-reports-third-quarter-2017-results'>Press Release</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3302362\" data-linked=\"PayPal beats by $0.03, beats on revenue\" data-tweet=\"$PYPL - PayPal beats by $0.03, beats on revenue https://seekingalpha.com/news/3302362-paypal-beats-0_03-beats-on-revenue?source=tweet\" data-url=\"https://seekingalpha.com/news/3302362-paypal-beats-0_03-beats-on-revenue\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:11 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>26&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3302360\" data-ts=\"1508443837\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MXIM\" target=\"_blank\">MXIM</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3302360-maxim-integrated-products-beats-0_04-misses-on-revenue\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Maxim Integrated Products beats by $0.04, misses on revenue</a></h4><ul><li>Maxim Integrated Products (NASDAQ:<a href='https://seekingalpha.com/symbol/MXIM' title='Maxim Integrated Products, Inc.'>MXIM</a>): Q1 EPS of $0.60 <font color='green'>beats by $0.04</font>.</li><li>Revenue of $575.68M (+2.5% Y/Y) <font color='red'>misses by $1.07M</font>.</li><li>Shares <font color='green'>+1.8%</font>.</li><li><a href='https://seekingalpha.com/pr/16974374-maxim-integrated-reports-results-first-quarter-fiscal-2018'>Press Release</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3302360\" data-linked=\"Maxim Integrated Products beats by $0.04, misses on revenue\" data-tweet=\"$MXIM - Maxim Integrated Products beats by $0.04, misses on revenue https://seekingalpha.com/news/3302360-maxim-integrated-products-beats-0_04-misses-on-revenue?source=tweet\" data-url=\"https://seekingalpha.com/news/3302360-maxim-integrated-products-beats-0_04-misses-on-revenue\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:10 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3302357\" data-ts=\"1508443688\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ISRG\" target=\"_blank\">ISRG</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3302357-intuitive-surgical-beats-0_78-beats-on-revenue\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Intuitive Surgical beats by $0.78, beats on revenue</a></h4><ul><li>Intuitive Surgical (NASDAQ:<a href='https://seekingalpha.com/symbol/ISRG' title='Intuitive Surgical, Inc.'>ISRG</a>): Q3 EPS of $2.77 <font color='green'>beats by $0.78</font>.</li><li>Revenue of $806.1M (+18.0% Y/Y) <font color='green'>beats by $52.95M</font>.</li><li>Shares <font color='green'>+2.9%</font>.</li><li><a href='https://seekingalpha.com/pr/16974380-intuitive-surgical-announces-third-quarter-earnings'>Press Release</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3302357\" data-linked=\"Intuitive Surgical beats by $0.78, beats on revenue\" data-tweet=\"$ISRG - Intuitive Surgical beats by $0.78, beats on revenue https://seekingalpha.com/news/3302357-intuitive-surgical-beats-0_78-beats-on-revenue?source=tweet\" data-url=\"https://seekingalpha.com/news/3302357-intuitive-surgical-beats-0_78-beats-on-revenue\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:08 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>19&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3302355\" data-ts=\"1508443675\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SFIX\" target=\"_blank\">SFIX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3302355-stitch-fix-files-for-ipo\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Stitch Fix files for IPO</a></h4><ul><li>Stitch Fix (<a href='https://seekingalpha.com/symbol/SFIX' title='Stitch Fix, Inc.'>SFIX</a>) files for an IPO. The initial registration amount on the filing is for $100M.</li><li>The online subscription and personal shopping service has been turning some heads in the retail sector with it now offering access to 700 brands.</li><li>Stitch Fix reported revenue of $730M in 2016, up from $73M in 2014. Net income was $33M in 2016.</li><li><a href=\"https://www.sec.gov/Archives/edgar/data/1576942/000119312517313629/d400510ds1.htm\" target=\"_blank\">SEC Form S-1</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3302355\" data-linked=\"Stitch Fix files for IPO\" data-tweet=\"$SFIX - Stitch Fix files for IPO https://seekingalpha.com/news/3302355-stitch-fix-files-for-ipo?source=tweet\" data-url=\"https://seekingalpha.com/news/3302355-stitch-fix-files-for-ipo\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:07 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3302353\" data-ts=\"1508443616\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SKX\" target=\"_blank\">SKX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3302353-skechers-beats-0_15-beats-on-revenue\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Skechers beats by $0.15, beats on revenue</a></h4><ul><li>Skechers (NYSE:<a href='https://seekingalpha.com/symbol/SKX' title='Skechers USA Inc.'>SKX</a>): Q3 EPS of $0.59 <font color='green'>beats by $0.15</font>.</li><li>Revenue of $1.1B (+16.7% Y/Y) <font color='green'>beats by $30M</font>.</li><li>Shares <font color='green'>+7%</font>.</li><li><a href='https://seekingalpha.com/pr/16974358-skechers-achieves-new-quarterly-sales-record-third-quarter-2017'>Press Release</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3302353\" data-linked=\"Skechers beats by $0.15, beats on revenue\" data-tweet=\"$SKX - Skechers beats by $0.15, beats on revenue https://seekingalpha.com/news/3302353-skechers-beats-0_15-beats-on-revenue?source=tweet\" data-url=\"https://seekingalpha.com/news/3302353-skechers-beats-0_15-beats-on-revenue\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:06 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>14&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3302342\" data-ts=\"1508443118\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GWW\" target=\"_blank\">GWW</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3302342-grainger-cut-to-sell-ubs-gross-margin-pressure-not-sufficiently-priced-in\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Grainger cut to Sell at UBS; gross margin pressure not sufficiently priced in</a></h4><ul>     <li>Grainger (<a href='https://seekingalpha.com/symbol/GWW' title='W.W. Grainger, Inc.'>GWW</a> <font color='red'>-2%</font>)&nbsp;is lower after UBS <a href=\"https://www.streetinsider.com/Analyst+PT+Change/UBS+Downgrades+WW+Grainger+%28GWW%29+to+Sell/13403352.html\" target=\"_blank\">downgrades shares to Sell</a> from Neutral with a $195 price target, as the firm believes the 2x multiple expansion and 15% run-up in the stock since the <a href=\"https://seekingalpha.com/news/3301446\" target=\"_blank\">Q3 earnings</a> report is unwarranted.</li>     <li>UBS still sees a high degree of uncertainty associated with the long-term risk of gross margin pressure  and the sustainability of offsets, and expects continued pricing pressure across the customer base, including  recurring contracts.</li>     <li>While GWW expects to offset gross margin pressure with cost actions, UBS thinks the actions could only temporarily benefit operating margin.</li>     <li>Oppenheimer upgraded shares <a href=\"https://seekingalpha.com/news/3301848\" target=\"_blank\">yesterday</a> on confidence in pricing for next year.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3302342\" data-linked=\"Grainger cut to Sell at UBS; gross margin pressure not sufficiently priced in\" data-tweet=\"$GWW - Grainger cut to Sell at UBS; gross margin pressure not sufficiently priced in https://seekingalpha.com/news/3302342-grainger-cut-to-sell-ubs-gross-margin-pressure-not-sufficiently-priced-in?source=tweet\" data-url=\"https://seekingalpha.com/news/3302342-grainger-cut-to-sell-ubs-gross-margin-pressure-not-sufficiently-priced-in\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:58 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3302336\" data-ts=\"1508442189\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/WTR\" target=\"_blank\">WTR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3302336-aqua-america-upped-wells-fargo-on-m-view-pennsylvania-rate-case\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Aqua America upped at Wells Fargo on M&amp;A view, Pennsylvania rate case</a></h4><ul>     <li>Aqua America (<a href='https://seekingalpha.com/symbol/WTR' title='Aqua America, Inc.'>WTR</a> <font color='green'>+1.9%</font>) is <a href=\"https://www.benzinga.com/analyst-ratings/analyst-color/17/10/10200107/aqua-america-upgraded-on-m-a-prospects\" target=\"_blank\">upgraded</a> to Outperform from Market Perform with a $40 price target, raised from $35, at Wells Fargo, citing management's focus on tuck-in M&amp;A and expectations for a constructive outcome in the upcoming Pennsylvania rate relief case.</li>     <li>The firm notes that its earnings outlook for WTR incorporates only $50M of deals in 2018 and beyond vs. the $120M-plus pending, so it foresees potential upside to its view if the accelerated pace continues.</li>     <li>Wells also anticipates a positive outcome in the coming Pennsylvania rate case, as WTR indicated it would file an infrastructure charge in 2017 and the rate case filing likely will occur in 2018 with a resolution expected in 2019.</li></ul><div class=\"tiny-share-widget\" data-id=\"3302336\" data-linked=\"Aqua America upped at Wells Fargo on M&amp;A view, Pennsylvania rate case\" data-tweet=\"$WTR - Aqua America upped at Wells Fargo on M&amp;A view, Pennsylvania rate case https://seekingalpha.com/news/3302336-aqua-america-upped-wells-fargo-on-m-view-pennsylvania-rate-case?source=tweet\" data-url=\"https://seekingalpha.com/news/3302336-aqua-america-upped-wells-fargo-on-m-view-pennsylvania-rate-case\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:43 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>10&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3302329\" data-ts=\"1508441534\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ATHN\" target=\"_blank\">ATHN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3302329-athenahealth-cuts-400-jobs-ahead-of-q3-earnings-shares-down-4\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Athenahealth cuts 400 jobs ahead of Q3 earnings; shares down 4%</a></h4><ul><li>Athenahealth (<a href='https://seekingalpha.com/symbol/ATHN' title='athenahealth, Inc.'>ATHN</a> <font color='red'>-3.5%</font>) slips on modestly higher volume on the heels of a <a href=\"https://www.bizjournals.com/boston/news/2017/10/19/athenahealth-lays-off-hundreds-of-workers-sources.html\" target=\"_blank\">report </a>that it has eliminated more than 400 positions ahead of this afternoon's Q3 earnings announcement. It is unclear how many of the jobs affected were based out of its Watertown, MA headquarters.</li><li>Consensus view is EPS of $0.50 on revenues of $310.5M.</li></ul><div class=\"tiny-share-widget\" data-id=\"3302329\" data-linked=\"Athenahealth cuts 400 jobs ahead of Q3 earnings; shares down 4%\" data-tweet=\"$ATHN - Athenahealth cuts 400 jobs ahead of Q3 earnings; shares down 4% https://seekingalpha.com/news/3302329-athenahealth-cuts-400-jobs-ahead-of-q3-earnings-shares-down-4?source=tweet\" data-url=\"https://seekingalpha.com/news/3302329-athenahealth-cuts-400-jobs-ahead-of-q3-earnings-shares-down-4\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:32 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3302333\" data-ts=\"1508441217\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PRAN\" target=\"_blank\">PRAN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3302333-prana-bio-up-28-following-research-collaboration-takeda\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Prana Bio up 28% following research collaboration with Takeda</a></h4><ul><li>Thinly traded nano cap Prana Biotechnology (<a href='https://seekingalpha.com/symbol/PRAN' title='Prana Biotechnology Ltd'>PRAN</a> <font color='green'>+28%</font>) is up on a healthy 49x surge in volume. Yesterday, it <a href=\"https://seekingalpha.com/pr/16889280-prana-commences-research-collaboration-takeda-treatment-parkinsons-disease-gastrointestinal\" target=\"_blank\">announced </a>a research collaboration with Takeda Pharmaceuticals International (TKPYY <font color='green'>+0.4%</font>) to study the ability of PBT434 to slow or prevent neurodegeneration of the gastrointestinal system, characteristic of Parkinson's disease.</li><li>The research will explore PBT434's effect on GI dysfunction, including constipation, lowered colon motility and inflammation.</li><li>A recent paper published in <em>Acta Neuropathologica Communications</em>, suggested that PBT434 may reduce iron-mediated neurodegeneration and alpha-synuclein toxicity by reducing the formation of certain aggregates, freeing rescue neurons to restore motor function.</li></ul><div class=\"tiny-share-widget\" data-id=\"3302333\" data-linked=\"Prana Bio up 28% following research collaboration with Takeda\" data-tweet=\"$PRAN $ATHE $TAK - Prana Bio up 28% following research collaboration with Takeda https://seekingalpha.com/news/3302333-prana-bio-up-28-following-research-collaboration-takeda?source=tweet\" data-url=\"https://seekingalpha.com/news/3302333-prana-bio-up-28-following-research-collaboration-takeda\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:26 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3302331\" data-ts=\"1508441019\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3302331-afternoon-rally-brings-s-and-p-500-back-to-flat\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Afternoon rally brings S&amp;P 500 back to flat</a></h4><ul><li>Stocks had the temerity to go lower overnight and early in the session, but that offense has been corrected in afternoon action. Less than 40 minutes before the close, both the S&amp;P 500 and DJIA are flat, and the Nasdaq - off nearly 1% at one point - is<font color='red'> down just 0.35%</font>.</li><li>S&amp;P 500 futures were as low as 2,542 overnight, but have now bounced to 2,558.</li></ul><div class=\"tiny-share-widget\" data-id=\"3302331\" data-linked=\"Afternoon rally brings S&amp;P 500 back to flat\" data-tweet=\"Afternoon rally brings S&amp;P 500 back to flat https://seekingalpha.com/news/3302331-afternoon-rally-brings-s-and-p-500-back-to-flat?source=tweet\" data-url=\"https://seekingalpha.com/news/3302331-afternoon-rally-brings-s-and-p-500-back-to-flat\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:23 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3302330\" data-ts=\"1508440626\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/RCI\" target=\"_blank\">RCI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3302330-rogers-communicationsminus-1_7-revenue-lags-expectations\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Rogers Communications -1.7% as revenue lags expectations</a></h4><ul>   <li>Rogers Communications (NYSE:<a href='https://seekingalpha.com/symbol/RCI' title='Rogers Communications Inc.'>RCI</a>) is <font color='red'>off 1.7%</font> in U.S. trading after posting <a href=\"https://seekingalpha.com/news/3302110-rogers-reports-q3-results\" target=\"_blank\">Q3 earnings</a> where adjusted profits exceeded expectations, but revenue grew more slowly than the Street hoped.</li>    <li>Revenues of C$3.58B missed expectations for C$3.63B. Overall revenues grew 3%; the vast bulk of that, service revenue, was up 4% to C$3.45B.</li>    <li>Adjusted operating profit was up 6% overall.</li>    <li>Revenues and operating profits grew in all segments except Media, which saw revenues slip 3% and profits fall 18%.</li>    <li>Postpaid net adds were 129,000 (up 15,000), the highest figure in eight years. Postpaid churn improved 10 basis points to 1.16%. In Internet, net adds came to 27,000.</li>    <li>Revenue by segment: Wireless, C$2.14B (up 5%); Cable, C$870M (up 1%); Business Solutions, C$97M (up 2%); Media, C$516M (down 3%).</li>    <li>Adjusted operating profit by segment: Wireless, C$964M (up 9%); Cable, C$440M (up 2%); Business Solutions, C$33M (up 6%); Media, C$65M (down 18%).</li>    <li>It's increasing full-year guidance for operating profit growth to 5-6%, and will reinvest in networks (it's revising total capex expectations to C$2.35B-C$2.45B, with free cash flow guidance at 2-4% growth).</li>    <li><a href=\"https://seekingalpha.com/pr/16973292-rogers-communications-reports-third-quarter-2017-results\" target=\"_blank\">Press Release</a></li> </ul><div class=\"tiny-share-widget\" data-id=\"3302330\" data-linked=\"Rogers Communications -1.7% as revenue lags expectations\" data-tweet=\"$RCI - Rogers Communications -1.7% as revenue lags expectations https://seekingalpha.com/news/3302330-rogers-communicationsminus-1_7-revenue-lags-expectations?source=tweet\" data-url=\"https://seekingalpha.com/news/3302330-rogers-communicationsminus-1_7-revenue-lags-expectations\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:17 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3302324\" data-ts=\"1508439564\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BHGE\" target=\"_blank\">BHGE</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3302324-baker-hughes-started-neutral-ubs-citing-fair-valuation\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Baker Hughes started at Neutral by UBS, citing fair valuation</a></h4><ul>     <li>Baker Hughes (<a href='https://seekingalpha.com/symbol/BHGE' title='Baker Hughes, a GE company'>BHGE</a> <font color='red'>-2%</font>)&nbsp;is initiated with a <a href=\"https://www.benzinga.com/analyst-ratings/analyst-color/17/10/10198584/baker-hughes-a-compelling-stock-for-the-conservative-in\" target=\"_blank\">Neutral rating</a> on valuation and $36 price target at UBS, which nevertheless thinks the stock is compelling for conservative investors looking for less leverage to oil prices, as well as for those seeking a strong balance sheet and a dividend.</li>     <li>UBS notes BHGE's strong balance sheet with $4B in cash with a 1.2x debt/EBITDA ratio for 2018, and it expects BHGE to generate a 5% free cash flow yield of 5 percent the strong financial positioning better allows the company to return a $0.17/share quarterly dividend, which could be expanded to include a $1B stock buyback program.</li>     <li>But for investors preferring exposure to the U.S. land market, the firm says BHGE offers less exposure than the legacy Baker Hughes.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3302324\" data-linked=\"Baker Hughes started at Neutral by UBS, citing fair valuation\" data-tweet=\"$BHGE $BKR - Baker Hughes started at Neutral by UBS, citing fair valuation https://seekingalpha.com/news/3302324-baker-hughes-started-neutral-ubs-citing-fair-valuation?source=tweet\" data-url=\"https://seekingalpha.com/news/3302324-baker-hughes-started-neutral-ubs-citing-fair-valuation\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:59 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3302323\" data-ts=\"1508439364\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3302323-technology-top-gainers-losers-of-2-55-pm\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Technology - Top Gainers / Losers as of 2:55 pm</a></h4><ul>     <li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/GRVY' title='GRAVITY Co., Ltd. - American depositary shares, each representing one'>GRVY</a> <font color='green'>+18%</font>. <a href='https://seekingalpha.com/symbol/VHC' title='VirnetX Holding Corporation'>VHC</a> <font color='green'>+16%</font>. <a href='https://seekingalpha.com/symbol/SILC' title='Silicom Ltd'>SILC</a> <font color='green'>+14%</font>. <a href='https://seekingalpha.com/symbol/MTSL' title='MER Telemanagement Solutions Ltd.'>MTSL</a> <font color='green'>+13%</font>. <a href='https://seekingalpha.com/symbol/ADBE' title='Adobe Systems Incorporated'>ADBE</a> <font color='green'>+12%</font>.</li><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/BHE' title='Benchmark Electronics Inc'>BHE</a> <font color='red'>-13%</font>. <a href='https://seekingalpha.com/symbol/RNVA' title='Rennova Health, Inc.'>OTCPK:RNVA</a> <font color='red'>-8%</font>. <a href='https://seekingalpha.com/symbol/PTI' title='Proteostasis Therapeutics'>PTI</a> <font color='red'>-8%</font>. <a href='https://seekingalpha.com/symbol/MTLS' title='Materialise NV'>MTLS</a> <font color='red'>-8%</font>. <a href='https://seekingalpha.com/symbol/VERI' title='Veritone'>VERI</a> <font color='red'>-8%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3302323\" data-linked=\"Technology - Top Gainers / Losers as of 2:55 pm\" data-tweet=\"$GRVY $VHC $SILC - Technology - Top Gainers / Losers as of 2:55 pm https://seekingalpha.com/news/3302323-technology-top-gainers-losers-of-2-55-pm?source=tweet\" data-url=\"https://seekingalpha.com/news/3302323-technology-top-gainers-losers-of-2-55-pm\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:56 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3302322\" data-ts=\"1508439238\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/OCN\" target=\"_blank\">OCN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3302322-ocwen-up-nearly-5-amid-sale-chatter\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Ocwen up nearly 5% amid sale chatter</a></h4><ul><li>Buried at the bottom of a recent filing was news Ocwen Financial (<a href='https://seekingalpha.com/symbol/OCN' title='Ocwen Financial Corporation'>OCN</a> <font color='green'>+4.5%</font>) is selling its wholesale-broker division, <a href=\"https://www.insidemortgagefinance.com/imfnews/1_1216/daily/Ocwen-sale-of-wholesale-sparks-m-and-a-rumor-1000043301-1.html?ET=imfpubs:e9957:61888a:&amp;st=email&amp;s=imfnews\" target=\"_blank\">according to Inside Mortgage Finance</a>.</li><li>The news is raising questions about the company's future as an originator, or as a possible acquisition target.</li><li>Speculating on a big jump in Nationstar Mortgage's (NYSE:<a href='https://seekingalpha.com/symbol/NSM' title='Nationstar Mortgage Holdings'>NSM</a>) share price yesterday, Wedbush wonders about a potential sale of its Xome unit or a potential purchase of some or all of Ocwen's servicing business.</li><li>Ocwen&nbsp;<font color='green'>up 4.5%&nbsp;</font>to $3.97</li><li>Previously: <a href=\"https://seekingalpha.com/news/3302123-ocwen-settles-one-state\" target=\"_blank\">Ocwen settles with one more state</a> (Oct. 19)</li></ul><div class=\"tiny-share-widget\" data-id=\"3302322\" data-linked=\"Ocwen up nearly 5% amid sale chatter\" data-tweet=\"$OCN $OCN $NSM - Ocwen up nearly 5% amid sale chatter https://seekingalpha.com/news/3302322-ocwen-up-nearly-5-amid-sale-chatter?source=tweet\" data-url=\"https://seekingalpha.com/news/3302322-ocwen-up-nearly-5-amid-sale-chatter\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:53 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>15&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3302319\" data-ts=\"1508438860\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SLB\" target=\"_blank\">SLB</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3302319-new-schlumberger-deal-raises-concerns-diversification-strategy\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">New Schlumberger deal raises concerns about its diversification strategy</a></h4><ul>     <li>Schlumberger's (<a href='https://seekingalpha.com/symbol/SLB' title='Schlumberger Limited'>SLB</a> <font color='red'>-1.8%</font>) deal to <a href=\"https://seekingalpha.com/news/3302103-cenovus-sell-palliser-assets-schlumberger-torxen-c-1_3b\" target=\"_blank\">buy oil and gas assets</a> worth $1B from Cenovus Energy (<a href='https://seekingalpha.com/symbol/CVE' title='Cenovus Energy, Inc.'>CVE</a> <font color='green'>+1.3%</font>) is <a href=\"http://www.reuters.com/article/cenovus-energy-divestiture/update-3-schlumbergers-latest-asset-deal-raises-fresh-concerns-ahead-of-q3-idUSL4N1MU3ZO\" target=\"_blank\">raising fresh concerns</a> among analysts about SLB's strategy to own more refining and drilling operations directly.</li>     <li>SLB has poured ~$4.3B since 2012 into buying stakes in oil and gas projects to help diversify from its core services business, but the concern is how much the CVE deal actually diversifies risk, \"as acquiring E&amp;P assets implies taking on additional commodity risk, while international projects incur increased country risk,&rdquo; Barclays analysts say.</li>     <li>&ldquo;Investors have been asking a lot of questions about [SLB's] strategy, fearing the business adds uncertain risk to the company&rsquo;s earnings,&rdquo; says Cowen's Marc Bianchi at Cowen. &ldquo;As a majority non-op owner, it appears Schlumberger is taking commodity risk on this project.\"</li></ul><div class=\"tiny-share-widget\" data-id=\"3302319\" data-linked=\"New Schlumberger deal raises concerns about its diversification strategy\" data-tweet=\"$SLB $SLB $CVE - New Schlumberger deal raises concerns about its diversification strategy https://seekingalpha.com/news/3302319-new-schlumberger-deal-raises-concerns-diversification-strategy?source=tweet\" data-url=\"https://seekingalpha.com/news/3302319-new-schlumberger-deal-raises-concerns-diversification-strategy\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:47 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>24&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3302318\" data-ts=\"1508438786\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/UAL\" target=\"_blank\">UAL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3302318-investors-punish-united-continental\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Investors punish United Continental</a></h4><ul>     <li>United Continental (NASDAQ:<a href='https://seekingalpha.com/symbol/UAL' title='United Continental Holdings, Inc'>UAL</a>) is down a&nbsp;<font color='red'>clean 10%</font>&nbsp;after the airline company's Q3 guidance for pre-tax margin rate and unit revenue disappoints investors.</li>     <li>The airline is getting punished for financial metrics that aren't quite keeping up with peers.</li><li>\"We have dug ourselves in a hole from a competitive perspective,\" CEO Oscar Munoz admitted on today's earnings call.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3301982-united-tops-estimates-hurricane-impacted-quarter\" target=\"_blank\">United tops estimates for hurricane-impacted quarter</a> (Oct. 18)</li> </ul><div class=\"tiny-share-widget\" data-id=\"3302318\" data-linked=\"Investors punish United Continental\" data-tweet=\"$UAL - Investors punish United Continental https://seekingalpha.com/news/3302318-investors-punish-united-continental?source=tweet\" data-url=\"https://seekingalpha.com/news/3302318-investors-punish-united-continental\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:46 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>52&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3302316\" data-ts=\"1508437828\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3302316-financials-top-5-gainers-losers-of-2-30-pm\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Financials - Top 5 Gainers / Losers as of 2:30 PM</a></h4><ul><li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/HCC' title='Warrior Met Coal'>HCC</a> <font color='green'>+13%</font>. <a href='https://seekingalpha.com/symbol/NNI' title='Nelnet, Inc.'>NNI</a> <font color='green'>+9%</font>. <a href='https://seekingalpha.com/symbol/OCN' title='Ocwen Financial Corporation'>OCN</a> <font color='green'>+6%</font>.</li><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/GROW' title='U.S. Global Investors, Inc.'>GROW</a> <font color='red'>-10%</font>. <a href='https://seekingalpha.com/symbol/BCRH' title='Blue Capital Reinsurance Holdings Ltd.'>BCRH</a> <font color='red'>-10%</font>. <a href='https://seekingalpha.com/symbol/FRSX' title='Foresight Autonomous Holdings Ltd.'>FRSX</a> <font color='red'>-9%</font>. <a href='https://seekingalpha.com/symbol/SLM' title='SLM Corporation'>SLM</a> <font color='red'>-6%</font>. <a href='https://seekingalpha.com/symbol/LEJU' title='Leju Holdings Limited'>LEJU</a> <font color='red'>-6%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3302316\" data-linked=\"Financials - Top 5 Gainers / Losers as of 2:30 PM\" data-tweet=\"$HCC $NNI $OCN - Financials - Top 5 Gainers / Losers as of 2:30 PM https://seekingalpha.com/news/3302316-financials-top-5-gainers-losers-of-2-30-pm?source=tweet\" data-url=\"https://seekingalpha.com/news/3302316-financials-top-5-gainers-losers-of-2-30-pm\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:30 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3302314\" data-ts=\"1508436950\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/OPTT\" target=\"_blank\">OPTT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3302314-ocean-power-techminus-33-after-pricing-stock-offering-1_42-share\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Ocean Power Tech -33% after pricing stock offering $1.42/share</a></h4><ul>     <li>Ocean Power Technologies (<a href='https://seekingalpha.com/symbol/OPTT' title='Ocean Power Technologies, Inc.'>OPTT</a> <font color='red'>-33%</font>) drops by a third after pricing its best efforts <a href=\"https://seekingalpha.com/pr/16973754-ocean-power-technologies-inc-prices-8150-000-offering-common-stock\" target=\"_blank\">public offering</a> of more than 5.7M shares at $1.42 each for ~$8.15M in gross proceeds.</li>     <li>The stock has given back all gains achieved <a href=\"https://seekingalpha.com/news/3301860-ocean-power-tech-plus-40-percent-patent-approval\" target=\"_blank\">yesterday</a> after winning a patent for a wave energy system that harnesses free power from the ocean.</li></ul><div class=\"tiny-share-widget\" data-id=\"3302314\" data-linked=\"Ocean Power Tech -33% after pricing stock offering $1.42/share\" data-tweet=\"$OPTT - Ocean Power Tech -33% after pricing stock offering $1.42/share https://seekingalpha.com/news/3302314-ocean-power-techminus-33-after-pricing-stock-offering-1_42-share?source=tweet\" data-url=\"https://seekingalpha.com/news/3302314-ocean-power-techminus-33-after-pricing-stock-offering-1_42-share\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:15 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>11&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3302311\" data-ts=\"1508436881\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/IMDZ\" target=\"_blank\">IMDZ</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3302311-immune-designs-g100-orphan-drug-in-europe-for-follicular-lymphoma-shares-continue-slide-over\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Immune Design&#39;s G100 an Orphan Drug in Europe for follicular lymphoma; shares continue slide over late-stage study of CMB305, down 14%</a></h4><ul><li>The European Commission <a href=\"http://ec.europa.eu/health/documents/community-register/html/o1924.htm#proc139053\" target=\"_blank\">designates </a>Immune Design's (<a href='https://seekingalpha.com/symbol/IMDZ' title='Immune Design'>IMDZ</a> <font color='red'>-13.7%</font>) <a href=\"http://www.immunedesign.com/pipeline/\" target=\"_blank\">G100</a> (glucopyranosyl lipid A), a Toll-like Receptor-4 (TLR4) agonist, an Orphan Drug for the treatment of follicular lymphoma.</li><li>Among the benefits of Orphan Drug status in Europe is a 10-year period of market exclusivity for the indication, if approved.</li><li>Shares continue to sell off in apparent reaction to the timeline of its Phase 3 study of cancer vaccine candidate CMB305, shedding ~49% of their value this week.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3301912-immune-design-continues-freefall-20-percent\" target=\"_blank\">Immune Design continues freefall, down 20%</a> (Oct. 18)</li></ul><div class=\"tiny-share-widget\" data-id=\"3302311\" data-linked=\"Immune Design&#39;s G100 an Orphan Drug in Europe for follicular lymphoma; shares continue slide over late-stage study of CMB305, down 14%\" data-tweet=\"$IMDZ - Immune Design&#39;s G100 an Orphan Drug in Europe for follicular lymphoma; shares continue slide over late-stage study of CMB305, down 14% https://seekingalpha.com/news/3302311-immune-designs-g100-orphan-drug-in-europe-for-follicular-lymphoma-shares-continue-slide-over?source=tweet\" data-url=\"https://seekingalpha.com/news/3302311-immune-designs-g100-orphan-drug-in-europe-for-follicular-lymphoma-shares-continue-slide-over\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:14 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3302310\" data-ts=\"1508436180\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/FCAU\" target=\"_blank\">FCAU</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3302310-fiat-chrysler-in-reverse-on-china-worries\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Fiat Chrysler in reverse on China worries</a></h4><ul>     <li>Fiat Chrysler Automobiles (<a href='https://seekingalpha.com/symbol/FCAU' title='Fiat Chrysler Automobiles NV'>FCAU</a> <font color='red'>-2.5%</font>) trades sharply lower amid rising <a href=\"https://www.reuters.com/article/us-fiatchrysler-production/fiat-chrysler-shares-fall-as-it-plans-to-curb-production-idUSKBN1CO2G3\" target=\"_blank\">concerns</a> that the automaker's import issues in China will continue.</li>     <li>The compnay is reportedly lowering production at plants in Italy that make the Maserati Levante, Alfa Romeo Stelvio and Alpha Romeo Giulia due to the lower sales in China.</li><li>Today's selling pressure arrives after a stellar +80% YTD&nbsp;run higher for Fiat shares.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3302310\" data-linked=\"Fiat Chrysler in reverse on China worries\" data-tweet=\"$FCAU - Fiat Chrysler in reverse on China worries https://seekingalpha.com/news/3302310-fiat-chrysler-in-reverse-on-china-worries?source=tweet\" data-url=\"https://seekingalpha.com/news/3302310-fiat-chrysler-in-reverse-on-china-worries\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:03 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3302308\" data-ts=\"1508436070\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3302308-energy-materials-top-gainers-losers-of-2-00-pm\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Energy/Materials - Top Gainers / Losers as of 2:00 pm</a></h4><ul>     <li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/DELT' title='Delta Technology Holdings Limited'>DELT</a> <font color='green'>+12%</font>. <a href='https://seekingalpha.com/symbol/IIIN' title='Insteel Industries, Inc.'>IIIN</a> <font color='green'>+6%</font>.</li><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/ESTE' title='Earthstone Energy, Inc.'>ESTE</a> <font color='red'>-15%</font>. <a href='https://seekingalpha.com/symbol/USAU' title='U.S. Gold Corp.'>USAU</a> <font color='red'>-9%</font>. <a href='https://seekingalpha.com/symbol/RCON' title='Recon Technology, Ltd.'>RCON</a> <font color='red'>-8%</font>. <a href='https://seekingalpha.com/symbol/HOS' title='Hornbeck Offshore Services, Inc.'>HOS</a> <font color='red'>-7%</font>. <a href='https://seekingalpha.com/symbol/KALU' title='Kaiser Aluminum Corporation'>KALU</a> <font color='red'>-6%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3302308\" data-linked=\"Energy/Materials - Top Gainers / Losers as of 2:00 pm\" data-tweet=\"$DELT-OLD $IIIN $ESTE - Energy/Materials - Top Gainers / Losers as of 2:00 pm https://seekingalpha.com/news/3302308-energy-materials-top-gainers-losers-of-2-00-pm?source=tweet\" data-url=\"https://seekingalpha.com/news/3302308-energy-materials-top-gainers-losers-of-2-00-pm\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:01 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3302303\" data-ts=\"1508435148\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TRCO\" target=\"_blank\">TRCO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3302303-tribune-media-shareholders-approve-3_9b-sinclair-buyout\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Tribune Media shareholders approve $3.9B Sinclair buyout</a></h4><ul>   <li>Shareholders for Tribune Media (<a href=\"http://seekingalpha.com/symbol/TRCO\" target=\"_blank\">TRCO</a> <font color='red'>-0.5%</font>) have <a href=\"https://seekingalpha.com/pr/16974135-tribune-media-company-stockholders-approve-sinclair-merger\" target=\"_blank\">overwhelmingly approved</a> of the company's takeover by Sinclair Broadcast Group (<a href=\"http://seekingalpha.com/symbol/SBGI\" target=\"_blank\">SBGI</a> <font color='red'>-1.8%</font>).</li>    <li>More than 99% of votes cast -- about 85% of outstanding shares of Class A and Class B common stock -- were voted in favor of the merger, Tribune says.</li>    <li>Yesterday, the FCC <a href=\"https://seekingalpha.com/news/3302036-fcc-pauses-review-3_9b-sinclair-tribune-deal-comment\" target=\"_blank\">paused its review of the $3.9B deal</a> to allow a couple more weeks of public comment.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3302303\" data-linked=\"Tribune Media shareholders approve $3.9B Sinclair buyout\" data-tweet=\"$TRCO $TRCO $SBGI - Tribune Media shareholders approve $3.9B Sinclair buyout https://seekingalpha.com/news/3302303-tribune-media-shareholders-approve-3_9b-sinclair-buyout?source=tweet\" data-url=\"https://seekingalpha.com/news/3302303-tribune-media-shareholders-approve-3_9b-sinclair-buyout\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:45 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3302300\" data-ts=\"1508434199\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SBH\" target=\"_blank\">SBH</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3302300-d-davidson-calls-sally-beauty-potential-amazon-target\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">D.A. Davidson calls Sally Beauty a potential Amazon target</a></h4><ul><li>D.A. Davidson suggests that Sally Beauty Holdings (<a href='https://seekingalpha.com/symbol/SBH' title='Sally Beauty Holdings, Inc.'>SBH</a> <font color='red'>-5.2%</font>) might make an intriguing target for Amazon.</li><li>The firm notes that Sally Beauty's store base could be a good way for the e-commerce giant to make a stronger play into the beauty sector.</li><li>Sources: <a href=\"https://twitter.com/thenotablecalls/status/921063007626715136\" target=\"_blank\">NotableCalls</a> and Bloomberg</li><li>Shares of Sally Beauty have tracked off the 52-week low of $16.35 that was carved out earlier.</li></ul><div class=\"tiny-share-widget\" data-id=\"3302300\" data-linked=\"D.A. Davidson calls Sally Beauty a potential Amazon target\" data-tweet=\"$SBH - D.A. Davidson calls Sally Beauty a potential Amazon target https://seekingalpha.com/news/3302300-d-davidson-calls-sally-beauty-potential-amazon-target?source=tweet\" data-url=\"https://seekingalpha.com/news/3302300-d-davidson-calls-sally-beauty-potential-amazon-target\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:29 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>9&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3302293\" data-ts=\"1508433273\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CVRS\" target=\"_blank\">CVRS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3302293-corindus-vascular-slips-11-on-bearish-cliffside-report\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Corindus Vascular slips 11% on bearish CLIFFSIDE report</a></h4><ul><li>Corindus Vascular Robotics (<a href='https://seekingalpha.com/symbol/CVRS' title='Corindus Vascular Robotics, Inc.'>CVRS</a> <font color='red'>-11.2%</font>) is under pressure in apparent response to a bearish <a href=\"http://www.cliffsideresearch.com/uploads/7/8/3/5/78352072/cvrs.pdf\" target=\"_blank\">report </a>by CLIFFSIDE Research that rates the stock a Strong Sell with a $0.46 (59% downside risk) price target.</li><li>The main thesis is the lack of value-add of its CorPath system, saying it cannot perform ~80% of complex PCI (percutaneous coronary intervention) procedures on its own and an alternative solution, called Zero-Gravity, costing a fraction of CorPath, provides equivalent radiation protection and relieves physicians of orthopedic strain and fatigue. It points out that only 51 CorPath systems have been installed over the past five years.</li></ul><div class=\"tiny-share-widget\" data-id=\"3302293\" data-linked=\"Corindus Vascular slips 11% on bearish CLIFFSIDE report\" data-tweet=\"$CVRS - Corindus Vascular slips 11% on bearish CLIFFSIDE report https://seekingalpha.com/news/3302293-corindus-vascular-slips-11-on-bearish-cliffside-report?source=tweet\" data-url=\"https://seekingalpha.com/news/3302293-corindus-vascular-slips-11-on-bearish-cliffside-report\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:14 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3302288\" data-ts=\"1508431783\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CNCE\" target=\"_blank\">CNCE</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3302288-uspto-rejects-incytes-challenge-to-concert-pharma-patent-shares-up-5\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">USPTO rejects Incyte&#39;s challenge to Concert Pharma patent; shares up 5%</a></h4><ul><li>Thinly traded micro cap Concert Pharmaceuticals (<a href='https://seekingalpha.com/symbol/CNCE' title='Concert Pharmaceuticals, Inc.'>CNCE</a> <font color='green'>+4.8%</font>) perks up on more than double normal volume, albeit on turnover of only 271K shares, in apparent response to the news that the USPTO's Patent Trial and Appeal Board &#40;PTAB&#41; has rejected Incyte's (<a href='https://seekingalpha.com/symbol/INCY' title='Incyte Corporation'>INCY</a> <font color='red'>-1%</font>) petition for inter partes review of Concert's patent covering deuterated derivatives of ruxolitinib (Jakafi).</li><li>Incyte challenged the patent on the basis of prior art, meaning the information supporting the patent was publicly available beforehand which would invalidate the originality of the patent.</li></ul><div class=\"tiny-share-widget\" data-id=\"3302288\" data-linked=\"USPTO rejects Incyte&#39;s challenge to Concert Pharma patent; shares up 5%\" data-tweet=\"$CNCE $CNCE $INCY - USPTO rejects Incyte&#39;s challenge to Concert Pharma patent; shares up 5% https://seekingalpha.com/news/3302288-uspto-rejects-incytes-challenge-to-concert-pharma-patent-shares-up-5?source=tweet\" data-url=\"https://seekingalpha.com/news/3302288-uspto-rejects-incytes-challenge-to-concert-pharma-patent-shares-up-5\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:49 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>12&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3302285\" data-ts=\"1508431204\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3302285-midday-gainers-losers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Midday Gainers / Losers</a></h4><ul>     <li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/IMMY-OLD' title='Imprimis Pharmaceuticals, Inc.'>IMMY-OLD</a> <font color='green'>+47%</font>. <a href='https://seekingalpha.com/symbol/QURE' title='uniQure N.V.'>QURE</a> <font color='green'>+47%</font>. ADHD <font color='green'>+35%</font>. <a href='https://seekingalpha.com/symbol/GNMX' title='Aevi Genomic Medicine, Inc.'>GNMX</a> <font color='green'>+28%</font>. <a href='https://seekingalpha.com/symbol/PRAN' title='Prana Biotechnology Ltd'>PRAN</a> <font color='green'>+20%</font>. <a href='https://seekingalpha.com/symbol/RWLK' title='ReWalk Robotics'>RWLK</a> <font color='green'>+16%</font>. <a href='https://seekingalpha.com/symbol/SILC' title='Silicom Ltd'>SILC</a> <font color='green'>+16%</font>. <a href='https://seekingalpha.com/symbol/ZDGE' title='Zedge, Inc.'>ZDGE</a> <font color='green'>+13%</font>. <a href='https://seekingalpha.com/symbol/CIDM' title='Cinedigm Corp.'>CIDM</a> <font color='green'>+14%</font>. <a href='https://seekingalpha.com/symbol/RGSE' title='RGS Energy, Inc.'>RGSE</a> <font color='green'>+14%</font>.</li><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/IMNP' title='Immune Pharmaceuticals Inc.'>OTCQB:IMNP</a> <font color='red'>-38%</font>. <a href='https://seekingalpha.com/symbol/OPTT' title='Ocean Power Technologies, Inc.'>OPTT</a> <font color='red'>-32%</font>. <a href='https://seekingalpha.com/symbol/CHFS' title='CHF Solutions, Inc.'>CHFS</a> <font color='red'>-17%</font>. <a href='https://seekingalpha.com/symbol/BHE' title='Benchmark Electronics Inc'>BHE</a> <font color='red'>-15%</font>. <a href='https://seekingalpha.com/symbol/ESTE' title='Earthstone Energy, Inc.'>ESTE</a> <font color='red'>-14%</font>. <a href='https://seekingalpha.com/symbol/UAL' title='United Continental Holdings, Inc'>UAL</a> <font color='red'>-12%</font>. <a href='https://seekingalpha.com/symbol/TRXC' title='TransEnterix, Inc.'>TRXC</a> <font color='red'>-11%</font>. <a href='https://seekingalpha.com/symbol/TRVN' title='Trevena, Inc.'>TRVN</a> <font color='red'>-10%</font>. <a href='https://seekingalpha.com/symbol/VTGN' title='VistaGen Therapeutics, Inc.'>VTGN</a> <font color='red'>-10%</font>. <a href='https://seekingalpha.com/symbol/HCCI' title='Heritage-Crystal Clean, Inc.'>HCCI</a> <font color='red'>-10%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3302285\" data-linked=\"Midday Gainers / Losers\" data-tweet=\"$IMMY-OLD $QURE $ARCT - Midday Gainers / Losers https://seekingalpha.com/news/3302285-midday-gainers-losers?source=tweet\" data-url=\"https://seekingalpha.com/news/3302285-midday-gainers-losers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:40 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>8&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3302278\" data-ts=\"1508430199\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BHE\" target=\"_blank\">BHE</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3302278-needham-downgrades-benchmark-electronics\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Needham downgrades Benchmark Electronics</a></h4><ul><li>        Needham <a href=\"http://www.briefing.com/DisplayArticle/ArticlePopup.aspx?ArticleId=IN20171019072549BHE\" target=\"_blank\">downgrades</a> Benchmark Electronics (NYSE:<a href='https://seekingalpha.com/symbol/BHE' title='Benchmark Electronics Inc'>BHE</a>)&nbsp;from Buy to Hold after Q3 results.</li><li>                  Benchmark beat estimates for the quarter but Q4 guidance missed consensus and Needham sees the pace of improvements slowing with valuation relatively high.    </li><li>               Needham moves to the sidelines believing Benchmark will continue to improve but needs to see more acceleration.&nbsp;</li><li>               Benchmark Electronics shares are&nbsp;<font color='red'>down 14.19%</font>. </li><li>Previously: <a href=\"https://seekingalpha.com/news/3301970-benchmark-electronics-reports-q3-beats-announces-cfo-retirement\" target=\"_blank\">Benchmark Electronics reports Q3 beats, announces CFO retirement</a> (Oct. 18)</li></ul><div class=\"tiny-share-widget\" data-id=\"3302278\" data-linked=\"Needham downgrades Benchmark Electronics\" data-tweet=\"$BHE - Needham downgrades Benchmark Electronics https://seekingalpha.com/news/3302278-needham-downgrades-benchmark-electronics?source=tweet\" data-url=\"https://seekingalpha.com/news/3302278-needham-downgrades-benchmark-electronics\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:23 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3302276\" data-ts=\"1508429692\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PRTY\" target=\"_blank\">PRTY</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3302276-party-city-slides-to-52-week-low\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Party City slides to 52-week low</a></h4><ul><li>Party City (NYSE:<a href='https://seekingalpha.com/symbol/PRTY' title='Party City Holdco, Inc.'>PRTY</a>)&nbsp;<font color='red'>slides 4.45%</font>&nbsp;as selling pressure on the retail stock continues.</li><li>Shares hit a new 52-week low of $11.05 earlier and are now down 23% YTD.</li><li>Party City is due to disclose earnings on November 9. Analysts expect the company to report revenue of $588M&nbsp;and EPS of $0.13.</li></ul><div class=\"tiny-share-widget\" data-id=\"3302276\" data-linked=\"Party City slides to 52-week low\" data-tweet=\"$PRTY - Party City slides to 52-week low https://seekingalpha.com/news/3302276-party-city-slides-to-52-week-low?source=tweet\" data-url=\"https://seekingalpha.com/news/3302276-party-city-slides-to-52-week-low\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:14 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3302274\" data-ts=\"1508429522\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AGEN\" target=\"_blank\">AGEN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3302274-agenus-down-10-on-planned-equity-offering\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Agenus down 10% on planned equity offering</a></h4><ul><li>Agenus (<a href='https://seekingalpha.com/symbol/AGEN' title='Agenus'>AGEN</a> <font color='red'>-9.8%</font>) slumps on triple normal volume in response to its filing of an <a href=\"https://www.sec.gov/Archives/edgar/data/1098972/000119312517312786/d476661ds3.htm\" target=\"_blank\">S-3 </a>yesterday after the close for a $250M mixed shelf offering.</li><li>A key looming event is the expected FDA approval of GlaxoSmithKline's Shingrix shingles vaccine which contains the company's Stimulon adjuvant.</li></ul><div class=\"tiny-share-widget\" data-id=\"3302274\" data-linked=\"Agenus down 10% on planned equity offering\" data-tweet=\"$AGEN - Agenus down 10% on planned equity offering https://seekingalpha.com/news/3302274-agenus-down-10-on-planned-equity-offering?source=tweet\" data-url=\"https://seekingalpha.com/news/3302274-agenus-down-10-on-planned-equity-offering\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:12 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>22&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3302272\" data-ts=\"1508428965\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GNMX\" target=\"_blank\">GNMX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3302272-aevi-perks-up-13-on-insider-activity\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Aevi perks up 13% on insider activity</a></h4><ul><li>Thinly traded nano cap Aevi Genomic Medicine (<a href='https://seekingalpha.com/symbol/GNMX' title='Aevi Genomic Medicine, Inc.'>GNMX</a> <font color='green'>+12.5%</font>) jumps on a 9x surge in volume in apparent response to Form 4 filings after the close yesterday disclosing stock purchases by insiders.</li><li>CEO <a href=\"https://www.sec.gov/Archives/edgar/data/1138776/000114420417053032/xslF345X03/tv477171_4.xml\" target=\"_blank\">Michael Cola</a>: 119,047 shares at $1.26.</li><li>CSO&nbsp;<a href=\"https://www.sec.gov/Archives/edgar/data/1138776/000114420417053027/xslF345X03/tv477166_4.xml\" target=\"_blank\">Garry Neil, M.D</a>.: 75,000 shares at $1.26.</li><li>Director <a href=\"https://www.sec.gov/Archives/edgar/data/1138776/000114420417053031/xslF345X03/tv477170_4.xml\" target=\"_blank\">Eugene Bauer</a>: 19,841 shares at $1.26.</li><li>Director <a href=\"https://www.sec.gov/Archives/edgar/data/1138776/000114420417053030/xslF345X03/tv477169_4.xml\" target=\"_blank\">Alastair Clemow</a>: 19,841 shares at $1.26.</li><li>Director <a href=\"https://www.sec.gov/Archives/edgar/data/1138776/000114420417053029/xslF345X03/tv477168_4.xml\" target=\"_blank\">Barbara Duncan</a>: 59,524 shares at $1.26.</li><li>Director <a href=\"https://www.sec.gov/Archives/edgar/data/1138776/000114420417053028/xslF345X03/tv477167_4.xml\" target=\"_blank\">Wilbur Gantz</a>: 39,683 shares at $1.26.</li><li>Director <a href=\"https://www.sec.gov/Archives/edgar/data/1138776/000114420417053026/xslF345X03/tv477165_4.xml\" target=\"_blank\">Joseph Grano</a>: 39,683 shares at $1.26.</li><li>Director <a href=\"https://www.sec.gov/Archives/edgar/data/1138776/000114420417053025/xslF345X03/tv477161_4.xml\" target=\"_blank\">Sol Barer</a>: 421,032 shares at $1.26.</li></ul><div class=\"tiny-share-widget\" data-id=\"3302272\" data-linked=\"Aevi perks up 13% on insider activity\" data-tweet=\"$GNMX - Aevi perks up 13% on insider activity https://seekingalpha.com/news/3302272-aevi-perks-up-13-on-insider-activity?source=tweet\" data-url=\"https://seekingalpha.com/news/3302272-aevi-perks-up-13-on-insider-activity\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:02 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3302270\" data-ts=\"1508428849\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3302270-consumer-top-gainers-losers-of-12-00-pm\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Consumer - Top Gainers / Losers as of 12:00 pm</a></h4><ul>     <li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/LBIX-OLD' title='Leading Brands Inc'>LBIX-OLD</a> <font color='green'>+14%</font>. <a href='https://seekingalpha.com/symbol/UQM' title='UQM Technologies, Inc'>UQM</a> <font color='green'>+9%</font>. <a href='https://seekingalpha.com/symbol/ADOM' title='ADOMANI, Inc.'>ADOM</a> <font color='green'>+6%</font>. <a href='https://seekingalpha.com/symbol/VRS' title='Verso Corporation'>VRS</a> <font color='green'>+6%</font>.</li><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/DFBG-OLD' title='Differential Brands Group Inc.'>DFBG-OLD</a> <font color='red'>-6%</font>. <a href='https://seekingalpha.com/symbol/UL' title='Unilever Plc'>UL</a> <font color='red'>-6%</font>. <a href='https://seekingalpha.com/symbol/UN' title='Unilever NV'>UN</a> <font color='red'>-5%</font>. <a href='https://seekingalpha.com/symbol/FCAU' title='Fiat Chrysler Automobiles NV'>FCAU</a> <font color='red'>-5%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3302270\" data-linked=\"Consumer - Top Gainers / Losers as of 12:00 pm\" data-tweet=\"$LBIX-OLD $UQM $ADOM - Consumer - Top Gainers / Losers as of 12:00 pm https://seekingalpha.com/news/3302270-consumer-top-gainers-losers-of-12-00-pm?source=tweet\" data-url=\"https://seekingalpha.com/news/3302270-consumer-top-gainers-losers-of-12-00-pm\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:00 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3302266\" data-ts=\"1508427523\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SBH\" target=\"_blank\">SBH</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3302266-sally-beauty-holdings-falls-after-wells-cut\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Sally Beauty Holdings falls after Wells cut</a></h4><ul><li>Shares of Sally Beauty Holdings (<a href='https://seekingalpha.com/symbol/SBH' title='Sally Beauty Holdings, Inc.'>SBH</a> <font color='red'>-5.3%</font>) fall after Wells Fargo cuts its price target by 20% on the personal care stock to $16.</li><li>Wells leans on what is becoming a familiar theme in the beauty sector, slowing growth trends and price competition, in making its call.</li><li>Sally Beauty Holdings trades at its lowest level since 2011.</li><li>Source: Bloomberg</li></ul><div class=\"tiny-share-widget\" data-id=\"3302266\" data-linked=\"Sally Beauty Holdings falls after Wells cut\" data-tweet=\"$SBH - Sally Beauty Holdings falls after Wells cut https://seekingalpha.com/news/3302266-sally-beauty-holdings-falls-after-wells-cut?source=tweet\" data-url=\"https://seekingalpha.com/news/3302266-sally-beauty-holdings-falls-after-wells-cut\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:38 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3302262\" data-ts=\"1508426774\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/DVAX\" target=\"_blank\">DVAX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3302262-dynavax-launches-study-to-identify-best-dose-of-inhaled-dv281-for-combo-study-pdminus-1\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Dynavax launches study to identify the best dose of inhaled DV281 for combo study with PD-1 inhibitor in lung cancer; shares up 2%</a></h4><ul><li>Dynavax (<a href='https://seekingalpha.com/symbol/DVAX' title='Dynavax Technologies Corporation'>DVAX</a> <font color='green'>+1.7%</font>) <a href=\"https://seekingalpha.com/pr/16973204-dynavax-initiates-clinical-trial-non-small-cell-lung-cancer-novel-inhaled-tlr9-agonist\" target=\"_blank\">initiates </a>a 24-subject, open-label Phase 1b dose escalation study to identify the optimum dose of inhaled toll-like receptor 9 (TLR9) agonist DV281 in patients with non-small cell lung cancer &#40;NSCLC&#41;. The most effective dose will be used in an expansion phase where it will be evaluated with a PD-1 inhibitor (e.g., Merck's Keytruda).</li><li>The company says it specifically formulated DV281 for inhalation to facilitate the delivery of a TLR9 agonist to lung tumors, not easily accessible via intratumoral injection.</li></ul><div class=\"tiny-share-widget\" data-id=\"3302262\" data-linked=\"Dynavax launches study to identify the best dose of inhaled DV281 for combo study with PD-1 inhibitor in lung cancer; shares up 2%\" data-tweet=\"$DVAX - Dynavax launches study to identify the best dose of inhaled DV281 for combo study with PD-1 inhibitor in lung cancer; shares up 2% https://seekingalpha.com/news/3302262-dynavax-launches-study-to-identify-best-dose-of-inhaled-dv281-for-combo-study-pdminus-1?source=tweet\" data-url=\"https://seekingalpha.com/news/3302262-dynavax-launches-study-to-identify-best-dose-of-inhaled-dv281-for-combo-study-pdminus-1\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:26 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>49&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3302254\" data-ts=\"1508425267\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3302254-healthcare-top-5-gainers-losers-of-11-00\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Healthcare - Top 5 Gainers / Losers as of 11:00 am</a></h4><ul>     <li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/IMMY-OLD' title='Imprimis Pharmaceuticals, Inc.'>IMMY-OLD</a> <font color='green'>+73%</font>. <a href='https://seekingalpha.com/symbol/QURE' title='uniQure N.V.'>QURE</a> <font color='green'>+58%</font>. ADHD <font color='green'>+39%</font>. <a href='https://seekingalpha.com/symbol/RWLK' title='ReWalk Robotics'>RWLK</a> <font color='green'>+16%</font>. <a href='https://seekingalpha.com/symbol/INFI' title='Infinity Pharmaceuticals, Inc.'>INFI</a> <font color='green'>+16%</font>.</li><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/IMNP' title='Immune Pharmaceuticals Inc.'>OTCQB:IMNP</a> <font color='red'>-40%</font>. <a href='https://seekingalpha.com/symbol/CHFS' title='CHF Solutions, Inc.'>CHFS</a> <font color='red'>-17%</font>. <a href='https://seekingalpha.com/symbol/AGEN' title='Agenus'>AGEN</a> <font color='red'>-14%</font>. <a href='https://seekingalpha.com/symbol/TRXC' title='TransEnterix, Inc.'>TRXC</a> <font color='red'>-13%</font>. <a href='https://seekingalpha.com/symbol/VTGN' title='VistaGen Therapeutics, Inc.'>VTGN</a> <font color='red'>-10%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3302254\" data-linked=\"Healthcare - Top 5 Gainers / Losers as of 11:00 am\" data-tweet=\"$IMMY-OLD $QURE $ARCT - Healthcare - Top 5 Gainers / Losers as of 11:00 am https://seekingalpha.com/news/3302254-healthcare-top-5-gainers-losers-of-11-00?source=tweet\" data-url=\"https://seekingalpha.com/news/3302254-healthcare-top-5-gainers-losers-of-11-00\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:01 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3302251\" data-ts=\"1508425104\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/RWLK\" target=\"_blank\">RWLK</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3302251-rewalk-robotics-up-20\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">ReWalk Robotics up 20%</a></h4><ul><li>Thinly traded nano cap ReWalk Robotics (<a href='https://seekingalpha.com/symbol/RWLK' title='ReWalk Robotics'>RWLK</a> <font color='green'>+20%</font>) is up on double normal volume. No particular news accounts for the action but the <a href=\"https://seekingalpha.com/pr/16970200-rewalk-robotics-launches-public-offering-ordinary-shares\" target=\"_blank\">pricing </a>for its public stock offering should be released any time.</li><li>Consensus Q3 view is a loss of ($0.35) per share on revenues of $1.6M.</li></ul><div class=\"tiny-share-widget\" data-id=\"3302251\" data-linked=\"ReWalk Robotics up 20%\" data-tweet=\"$RWLK - ReWalk Robotics up 20% https://seekingalpha.com/news/3302251-rewalk-robotics-up-20?source=tweet\" data-url=\"https://seekingalpha.com/news/3302251-rewalk-robotics-up-20\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:58 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3302249\" data-ts=\"1508424889\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/UN\" target=\"_blank\">UN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3302249-investors-react-to-weakness-unilever-and-nestle\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Investors react to weakness at Unilever and Nestle</a></h4><ul> <li>Unilever (<a href='https://seekingalpha.com/symbol/UN' title='Unilever NV'>UN</a>, <a href='https://seekingalpha.com/symbol/UL' title='Unilever Plc'>UL</a>) is <font color='red'>down 6%</font> after showing weak volume across different geographic regions in Q3.</li> <li>Analysts are pointing to the weak performance of the personal care business and were underwhelmed with the revenue guidance.</li> <li>Coupled with Nestle's (<a href='https://seekingalpha.com/symbol/NSRGY' title='Nestle S.A. ADR'>OTCPK:NSRGY</a>) expectations for weaker sales, the Unilever report is tilting sentiment in the consumer goods sector, including personal care products and food names.</li> <li>Notable decliners include Colgate-Palmolive (<a href='https://seekingalpha.com/symbol/CL' title='Colgate-Palmolive Co.'>CL</a> <font color='red'>-1.3%</font>), L'Oreal (<a href='https://seekingalpha.com/symbol/LRLCY' title='L&#39;Oreal Co. ADR'>OTCPK:LRLCY</a> <font color='red'>-1.1%</font>), Edgewell Personal Care (<a href='https://seekingalpha.com/symbol/EPC' title='Edgewell Personal Care'>EPC</a> <font color='red'>-2.4%</font>), Kimberly-Clark (<a href='https://seekingalpha.com/symbol/KMB' title='Kimberly-Clark Corporation'>KMB</a> <font color='red'>-1%</font>), General Mills (<a href='https://seekingalpha.com/symbol/GIS' title='General Mills, Inc.'>GIS</a> <font color='red'>-1.1%</font>), ConAgra Brands (<a href='https://seekingalpha.com/symbol/CAG' title='ConAgra Brands, Inc.'>CAG</a> <font color='red'>-1.3%</font>) and Procter &amp; Gamble (<a href='https://seekingalpha.com/symbol/PG' title='The Procter & Gamble Company'>PG</a> <font color='red'>-1.3%</font>).</li><li>The Consumer Staples Select Sector SPDR&nbsp;ETF (NYSEARCA:<a href='https://seekingalpha.com/symbol/XLP' title='Consumer Staples Select Sector SPDR ETF'>XLP</a>) is&nbsp;<font color='red'>down 0.7%</font>&nbsp;on the day.</li></ul><div class=\"tiny-share-widget\" data-id=\"3302249\" data-linked=\"Investors react to weakness at Unilever and Nestle\" data-tweet=\"$UN $UN $UL - Investors react to weakness at Unilever and Nestle https://seekingalpha.com/news/3302249-investors-react-to-weakness-unilever-and-nestle?source=tweet\" data-url=\"https://seekingalpha.com/news/3302249-investors-react-to-weakness-unilever-and-nestle\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:54 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>8&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3302248\" data-ts=\"1508424838\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/HCC\" target=\"_blank\">HCC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3302248-warrior-met-coalplus-10-on-plans-for-special-dividend-debt-offering\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Warrior Met Coal +10% on plans for special dividend, debt offering</a></h4><ul>     <li>Warrior Met Coal (<a href='https://seekingalpha.com/symbol/HCC' title='Warrior Met Coal'>HCC</a> <font color='green'>+9.8%</font>) surges on news that it plans to $350M in senior secured notes in a private offering to <a href=\"https://seekingalpha.com/pr/16973219-warrior-met-coal-launches-proposed-350-million-offering-senior-secured-notes\" target=\"_blank\">pay a special $600M cash dividend</a>.</li><li>Based on 53.44M shares outstanding as of July 31, the special dividend would <a href=\"http://www.marketwatch.com/story/warrior-met-coals-stock-soars-after-plans-for-special-dividend-debt-offering-2017-10-19\" target=\"_blank\">equal $11.23/share</a>, <em>MarketWatch</em> reports.</li><li>S&amp;P rates HCC's proposed debt at junk-level rating of B-, saying its rating is characterized by the company's \"narrow production base, low cash costs and volatile earnings owing to price an volume swings for metallurgical coal.\"</li></ul><div class=\"tiny-share-widget\" data-id=\"3302248\" data-linked=\"Warrior Met Coal +10% on plans for special dividend, debt offering\" data-tweet=\"$HCC - Warrior Met Coal +10% on plans for special dividend, debt offering https://seekingalpha.com/news/3302248-warrior-met-coalplus-10-on-plans-for-special-dividend-debt-offering?source=tweet\" data-url=\"https://seekingalpha.com/news/3302248-warrior-met-coalplus-10-on-plans-for-special-dividend-debt-offering\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:53 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>15&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3302246\" data-ts=\"1508424585\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/EVHC\" target=\"_blank\">EVHC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3302246-starboards-smith-bullish-on-envision-shares-up-6-ahead-of-ck4-presentation-in-toronto\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Starboard&#39;s Smith bullish on Envision; shares up 6% ahead of CK4 presentation in Toronto</a></h4><ul><li>Hospital-based physician group Envision Healthcare (<a href='https://seekingalpha.com/symbol/EVHC' title='Envision Healthcare Holdings'>EVHC</a> <font color='green'>+6.1%</font>) perks up on modestly higher volume in apparent response to an expected presentation by Starboard Value's Jeff Smith at the Capitalize for KIDS (C4K) Investors Conference in Toronto.</li><li>Mr. Smith is bullish on the company citing an attractive upside if it does more cross-selling in hospitals, cuts costs and consolidates headquarters. He also believes it is an attractive takeover candidate in light of its modest 9x EBITDA multiple. Competitor Team Head was acquired by Blackstone at a 12.4x multiple.</li><li>Source: Bloomberg</li></ul><div class=\"tiny-share-widget\" data-id=\"3302246\" data-linked=\"Starboard&#39;s Smith bullish on Envision; shares up 6% ahead of CK4 presentation in Toronto\" data-tweet=\"$EVHC - Starboard&#39;s Smith bullish on Envision; shares up 6% ahead of CK4 presentation in Toronto https://seekingalpha.com/news/3302246-starboards-smith-bullish-on-envision-shares-up-6-ahead-of-ck4-presentation-in-toronto?source=tweet\" data-url=\"https://seekingalpha.com/news/3302246-starboards-smith-bullish-on-envision-shares-up-6-ahead-of-ck4-presentation-in-toronto\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:49 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3302243\" data-ts=\"1508423837\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BDN\" target=\"_blank\">BDN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3302243-brandywine-realty-off-3-after-miss-guidance-cut-payout-hike-seen-for-2018\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Brandywine Realty off 3% after miss, guidance cut; payout hike seen for 2018</a></h4><ul><li>Q3 FFO of $61.9M or $0.35 per share vs. $58.3M and $0.33 one year ago. Expectations had been for $0.36. Dividend is $0.16, and the company expects to boost this by $0.02 next year.</li><li>Full-year FFO per share guidance is trimmed to $1.32-$1.34 from $1.34-$1.38. 2017 dispositions are now seen at $430M vs. the previous target of $200M.</li><li>Full-year 2018 FFO per share is seen at $1.36-$1.46.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3301951-brandywine-realty-trust-misses-0_01-misses-revenue\" target=\"_blank\">Brandywine Realty Trust misses by $0.01, misses on revenue</a> (Oct. 18)</li><li><a href='https://seekingalpha.com/symbol/BDN' title='Brandywine Realty Trust'>BDN</a>&nbsp;<font color='red'>-3.1%</font></li></ul><div class=\"tiny-share-widget\" data-id=\"3302243\" data-linked=\"Brandywine Realty off 3% after miss, guidance cut; payout hike seen for 2018\" data-tweet=\"$BDN - Brandywine Realty off 3% after miss, guidance cut; payout hike seen for 2018 https://seekingalpha.com/news/3302243-brandywine-realty-off-3-after-miss-guidance-cut-payout-hike-seen-for-2018?source=tweet\" data-url=\"https://seekingalpha.com/news/3302243-brandywine-realty-off-3-after-miss-guidance-cut-payout-hike-seen-for-2018\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:37 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3302242\" data-ts=\"1508423836\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CRT\" target=\"_blank\">CRT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3302242-anonymous-analytics-rates-criteo-strong-buy-criteo-names-new-cso\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Anonymous Analytics rates Criteo as Strong Buy; Criteo names new CSO</a></h4><ul><li>        Anonymous Analytics hits back at Gotham City Research&rsquo;s accusations against Criteo (NYSE:<a href='https://seekingalpha.com/symbol/CRT' title='Cross Timbers Royalty Trust'>CRT</a>).</li><li>               Anonymous&rsquo; <a href=\"http://www.anonanalytics.com/2017/10/criteo.html\" target=\"_blank\">report</a> calls Gotham&rsquo;s thesis &ldquo;highly flawed and misleading&rdquo; and says the other firm has &ldquo;a tenuous grasp of how internet traffic Is distributed.&rdquo;&nbsp;</li><li>               Anonymous rates Criteo a Strong Buy with a $64 target price.&nbsp;</li><li>               In other news, Criteo <a href=\"https://seekingalpha.com/pr/16973839-criteo-names-jonathan-opdyke-chief-strategy-officer\" target=\"_blank\">announces</a> the promotion of Jonathan Opdyke to Chief Strategy Officer.&nbsp;</li><li>                  Opdyke joined the company in 2016 as the President of Brand Solutions.    </li><li>                  Opdyke previously co-founded HookLogic, which Criteo later acquired.    </li><li>               Criteo shares are&nbsp;<font color='red'>down 1.58%</font>.&nbsp;&nbsp;</li><li>Previously: <a href=\"https://seekingalpha.com/news/3300728-criteo-shares-fall-accusation-illegal-harmful-practices\" target=\"_blank\">Criteo shares fall after accusation of \"illegal and harmful\" practices</a> (Oct. 12)</li><li>Previously: <a href=\"https://seekingalpha.com/news/3300980-criteo-hits-back-gotham-city-research-report\" target=\"_blank\">Criteo hits back at Gotham City Research report</a> (Oct. 13)</li></ul><div class=\"tiny-share-widget\" data-id=\"3302242\" data-linked=\"Anonymous Analytics rates Criteo as Strong Buy; Criteo names new CSO\" data-tweet=\"$CRT - Anonymous Analytics rates Criteo as Strong Buy; Criteo names new CSO https://seekingalpha.com/news/3302242-anonymous-analytics-rates-criteo-strong-buy-criteo-names-new-cso?source=tweet\" data-url=\"https://seekingalpha.com/news/3302242-anonymous-analytics-rates-criteo-strong-buy-criteo-names-new-cso\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:37 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3302241\" data-ts=\"1508423787\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SAH\" target=\"_blank\">SAH</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3302241-sonic-slides-after-baml-valuation-based-downgrade\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Sonic slides after BAML valuation-based downgrade</a></h4><ul> <li>Bank of America Merrill Lynch downgrades Sonic Automotive (NYSE:<a href='https://seekingalpha.com/symbol/SAH' title='Sonic Automotive Inc.'>SAH</a>) to Underperform from Neutral on concerns over valuation.</li> <li>The firm <a href=\"https://twitter.com/RatingsNetwork/status/920976888834809856\" target=\"_blank\">lowers</a> its price target on Sonic to $19, a level on fast approach with today's&nbsp;<font color='red'>7.40% drop</font>&nbsp;in share price.</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3302241\" data-linked=\"Sonic slides after BAML valuation-based downgrade\" data-tweet=\"$SAH - Sonic slides after BAML valuation-based downgrade https://seekingalpha.com/news/3302241-sonic-slides-after-baml-valuation-based-downgrade?source=tweet\" data-url=\"https://seekingalpha.com/news/3302241-sonic-slides-after-baml-valuation-based-downgrade\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:36 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3302222\" data-ts=\"1508423393\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/QURE\" target=\"_blank\">QURE</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3302222-uniqure-to-launch-pivotal-study-in-2018-for-promising-gene-therapy-candidate-amtminus-061-in\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">UniQure to launch pivotal study in 2018 for promising gene therapy candidate AMT-061 in hemophilia B; shares up 33%</a></h4><ul><li>Based on feedback from U.S. and European regulators, uniQure (<a href='https://seekingalpha.com/symbol/QURE' title='uniQure N.V.'>QURE</a> <font color='green'>+32.9%</font>) plans to <a href=\"https://seekingalpha.com/pr/16973265-uniqure-announces-hemophilia-b-gene-therapy-program-enter-pivotal-study-fix-padua-variant\" target=\"_blank\">initiate a pivotal study</a> next year assessing AMT-061 in patients with severe and moderately severe hemophilia B.</li><li>AMT-061 is structurally identical to AMT-060, already tested in 10 patients, but with two nucleotide substitutions in the coding sequence for factor IX &#40;FIX&#41;. The gene variant, called FIX-Padua, has shown an eight-to-nine-fold increase in FIX activity compared to wild-type FIX protein in preclinical testing.</li><li>The FDA has agreed to include AMT-061 in the existing Breakthrough Therapy designation and IND for AMT-060 while the EMA has signed off on including AMT-061 under the current PRIME designation.</li><li>The pivotal trial will be open-label and will evaluate a single dose of AMT-061. The primary endpoint will be the prevention of bleeds. Patients will serve as their own control with baselines established during a six-month lead-in phase.</li><li>Separately, the company has <a href=\"https://seekingalpha.com/pr/16973295-uniqure-strengthens-intellectual-property-portfolio-acquisition-patent-family-providing-broad\" target=\"_blank\">acquired </a>a patent family covering FIX-Padua from inventor Professor Paolo Simioni at the University of Padua, Italy.</li></ul><div class=\"tiny-share-widget\" data-id=\"3302222\" data-linked=\"UniQure to launch pivotal study in 2018 for promising gene therapy candidate AMT-061 in hemophilia B; shares up 33%\" data-tweet=\"$QURE - UniQure to launch pivotal study in 2018 for promising gene therapy candidate AMT-061 in hemophilia B; shares up 33% https://seekingalpha.com/news/3302222-uniqure-to-launch-pivotal-study-in-2018-for-promising-gene-therapy-candidate-amtminus-061-in?source=tweet\" data-url=\"https://seekingalpha.com/news/3302222-uniqure-to-launch-pivotal-study-in-2018-for-promising-gene-therapy-candidate-amtminus-061-in\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:29 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>7&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3302236\" data-ts=\"1508422969\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/VHC\" target=\"_blank\">VHC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3302236-virnetx-drops-after-preliminary-q3-results\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">VirnetX drops after preliminary Q3 results</a></h4><ul><li>        VirnetX (NYSEMKT:<a href='https://seekingalpha.com/symbol/VHC' title='VirnetX Holding Corporation'>VHC</a>) shares&nbsp;<font color='red'>drop 7.84%</font>&nbsp;after the company <a href=\"https://seekingalpha.com/filing/3731866\" target=\"_blank\">announces</a> preliminary Q3 results.</li><li>               Revenue is expected between $1M and $1.2M with loss per share from $0.18 to $0.20.&nbsp;</li><li>               Cash and equivalents will total $4.3M. &nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</li><li>Previously: <a href=\"https://seekingalpha.com/news/3301157-virnetx-announces-results-apple-patent-case-includes-1_20-per-device-update\" target=\"_blank\">VirnetX announces results of Apple patent case, includes $1.20 per device (update)</a> (Oct. 16)</li></ul><div class=\"tiny-share-widget\" data-id=\"3302236\" data-linked=\"VirnetX drops after preliminary Q3 results\" data-tweet=\"$VHC - VirnetX drops after preliminary Q3 results https://seekingalpha.com/news/3302236-virnetx-drops-after-preliminary-q3-results?source=tweet\" data-url=\"https://seekingalpha.com/news/3302236-virnetx-drops-after-preliminary-q3-results\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:22 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>5&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3302235\" data-ts=\"1508422882\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BK\" target=\"_blank\">BK</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3302235-bny-mellon-slips-nearly-3-despite-earnings-beat\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">BNY Mellon slips nearly 3% despite earnings beat</a></h4><ul><li>\"Our leadership team is not satisfied with our performance,\" says new BNY Mellon (<a href='https://seekingalpha.com/symbol/BK' title='The Bank of New York Mellon Corporation'>BK</a> <font color='red'>-2.8%</font>) CEO Charles Scharf. \"We see further opportunities to drive revenue growth and increase our efficiencies.\"</li><li>He notes businesses like asset servicing, clearing services, and investment management performed inline with expectations in Q3, but depositary receipts - which hit forex trading revenue - underperformed.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3302089-bank-new-york-mellon-beats-0_02-beats-revenue\" target=\"_blank\">Bank of New York Mellon beats by $0.02, beats on revenue</a> (Oct. 19)</li></ul><div class=\"tiny-share-widget\" data-id=\"3302235\" data-linked=\"BNY Mellon slips nearly 3% despite earnings beat\" data-tweet=\"$BK - BNY Mellon slips nearly 3% despite earnings beat https://seekingalpha.com/news/3302235-bny-mellon-slips-nearly-3-despite-earnings-beat?source=tweet\" data-url=\"https://seekingalpha.com/news/3302235-bny-mellon-slips-nearly-3-despite-earnings-beat\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:21 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3302230\" data-ts=\"1508422290\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/WPM\" target=\"_blank\">WPM</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3302230-3g-s-dreyfus-sees-wheaton-precious-metals-rising-to-mid-40s\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">3G\u2019s Dreyfus sees Wheaton Precious Metals rising to mid-$40s</a></h4><ul>     <li>Wheaton Precious Metals (NYSE:<a href='https://seekingalpha.com/symbol/WPM' title='Wheaton Precious Metals Corp'>WPM</a>) opens higher after 3G Capital&rsquo;s Dan Dreyfus tells the C4K Investors Conference in Toronto that he sees the stock climbing to the mid $40s, with the San Dimas mine and the resolution of the CRA audit as likely catalysts.</li><li>The dawn of the electric vehicle is here and it&rsquo;s going to happen fast, with the copper industry entering &ldquo;harvest mode,\"&nbsp;Dreyfus says; two WPM streams linked to copper projects include Hudbay and Salobo II.</li><li>Dreyfus says &ldquo;hidden assets&rdquo; could unlock another $10/share in value, with upside from a normalized gold/silver ratio possibly unlocking an additional $10.</li><li>Source:&nbsp;Bloomberg First Word</li> </ul><div class=\"tiny-share-widget\" data-id=\"3302230\" data-linked=\"3G\u2019s Dreyfus sees Wheaton Precious Metals rising to mid-$40s\" data-tweet=\"$WPM - 3G\u2019s Dreyfus sees Wheaton Precious Metals rising to mid-$40s https://seekingalpha.com/news/3302230-3g-s-dreyfus-sees-wheaton-precious-metals-rising-to-mid-40s?source=tweet\" data-url=\"https://seekingalpha.com/news/3302230-3g-s-dreyfus-sees-wheaton-precious-metals-rising-to-mid-40s\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:11 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>26&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3302220\" data-ts=\"1508421582\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CCL\" target=\"_blank\">CCL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3302220-weak-day-in-cruise-line-sector\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Weak day in the cruise line sector</a></h4><ul> <li>Cruise line stocks are lower as investors turn shy with earnings around the corner.</li> <li>Yesterday, M Science warned on Royal Caribbean's numbers and Carnival's CEO warned of a financial impact to the company from FEMA's use of ships during and after the Atlantic hurricanes.</li> <li>Carnival (NYSE:<a href='https://seekingalpha.com/symbol/CCL' title='Carnival Corporation'>CCL</a>) is <font color='red'>down 1.68%</font>, while Royal Caribbean (NYSE:<a href='https://seekingalpha.com/symbol/RCL' title='Royal Caribbean Cruises Ltd.'>RCL</a>) is <font color='red'>off 2.20%</font>. Shares of Norwegian Cruise Line Holdings (NASDAQ:<a href='https://seekingalpha.com/symbol/NCLH' title='Norwegian Cruise Line Holdings Ltd.'>NCLH</a>) are <font color='red'>down 4.19%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3302220\" data-linked=\"Weak day in the cruise line sector\" data-tweet=\"$CCL $CCL $RCL - Weak day in the cruise line sector https://seekingalpha.com/news/3302220-weak-day-in-cruise-line-sector?source=tweet\" data-url=\"https://seekingalpha.com/news/3302220-weak-day-in-cruise-line-sector\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:59 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3302218\" data-ts=\"1508421371\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/WIN\" target=\"_blank\">WIN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3302218-windstream-announces-debt-exchange-for-several-series\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Windstream announces debt exchange for several series</a></h4><ul>   <li>Windstream (<a href=\"http://seekingalpha.com/symbol/WIN\" target=\"_blank\">WIN</a> <font color='green'>+2.4%</font>) has announced a <a href=\"https://seekingalpha.com/pr/16973070-windstream-announces-debt-exchange-offers-consent-solicitations\" target=\"_blank\">debt exchange offer</a> for several series of upcoming notes.</li>    <li>It's offering to exchange any and all 7.5% senior notes due 2022 and 7.5% senior notes due 2023, for new senior notes due 2023.</li>    <li>The new notes will bear interest at 6 3/8%.</li>    <li>For the exchange, the older notes due 2022 will receive an early exchange consideration of $1,080 for each $1,000 in principal ($1,030 after the early tender date), and the notes due 2023 will receive early consideration of $1,075 for each $1,000 in principal ($1,025 for late exchange).</li>    <li>There is $441.15M outstanding of the 7.5% notes due 2022, and $343.46M outstanding of the 7.5% notes due 2023.</li>    <li>It's also offering to exchange 7.75% senior notes due 2021 ($809.3M outstanding) for new 6 3/8% notes or in some cases new 8.625% senior secured notes due 2025, as well as an offer to exchange 7.75% senior notes due 2020 ($650.95M outstanding) for new senior notes.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3302218\" data-linked=\"Windstream announces debt exchange for several series\" data-tweet=\"$WIN $WINMQ - Windstream announces debt exchange for several series https://seekingalpha.com/news/3302218-windstream-announces-debt-exchange-for-several-series?source=tweet\" data-url=\"https://seekingalpha.com/news/3302218-windstream-announces-debt-exchange-for-several-series\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:56 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>45&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3302217\" data-ts=\"1508421227\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AMZN\" target=\"_blank\">AMZN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3302217-amazons-wind-farm-is-up-and-running-deadline-day-for-hq2-proposals\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Amazon&#39;s wind farm is up and running; deadline day for HQ2 proposals</a></h4><ul><li>        Amazon&rsquo;s (NASDAQ:<a href='https://seekingalpha.com/symbol/AMZN' title='Amazon.com, Inc.'>AMZN</a>) largest wind farm is <a href=\"http://phx.corporate-ir.net/phoenix.zhtml?c=176060&amp;p=RssLanding&amp;cat=news&amp;id=2309819\" target=\"_blank\">now operational</a>.</li><li>               Amazon Wind Farm Texas has over 100 turbines and adds more than 1M MWh of clean energy each year.&nbsp;</li><li>               The farm brings Amazon&rsquo;s total wind and solar projects up to 18 in the United States. Amazon plans to create 35 more projects. &nbsp;&nbsp;</li><li>               HQ2 deadline: Today is the <a href=\"https://www.bloomberg.com/news/articles/2017-10-19/amazon-s-hq2-deadline-now-the-real-competition-begins\" target=\"_blank\">deadline</a> for cities to submit proposals for Amazon&rsquo;s second headquarters, HQ2.&nbsp;</li><li>               About 100 cities are expected to apply for HQ2, which will cost over $5B but create 50K jobs over two decades.&nbsp;</li><li>Amazon shares are&nbsp;<font color='red'>down 1.63%.</font>&nbsp;&nbsp;&nbsp;&nbsp;</li><li>Previously: <a href=\"https://seekingalpha.com/news/3302001-native-american-tribe-suing-microsoft-amazon-patents-holds\" target=\"_blank\">Native American tribe suing Microsoft, Amazon over patents it holds</a> (Oct. 18)</li></ul><div class=\"tiny-share-widget\" data-id=\"3302217\" data-linked=\"Amazon&#39;s wind farm is up and running; deadline day for HQ2 proposals\" data-tweet=\"$AMZN - Amazon&#39;s wind farm is up and running; deadline day for HQ2 proposals https://seekingalpha.com/news/3302217-amazons-wind-farm-is-up-and-running-deadline-day-for-hq2-proposals?source=tweet\" data-url=\"https://seekingalpha.com/news/3302217-amazons-wind-farm-is-up-and-running-deadline-day-for-hq2-proposals\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:53 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>23&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3302215\" data-ts=\"1508420899\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CDTX\" target=\"_blank\">CDTX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3302215-cidara-prices-private-placement-of-shares-6-shares-up-2\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Cidara prices private placement of shares at $6; shares up 2%</a></h4><ul><li>Cidara Therapeutics (<a href='https://seekingalpha.com/symbol/CDTX' title='Cidara Therapeutics'>CDTX</a> <font color='green'>+2.4%</font>) <a href=\"https://seekingalpha.com/pr/16973654-cidara-therapeutics-announces-pricing-20-million-private-placement-common-stock\" target=\"_blank\">prices </a>its direct sale of 3.36M shares of common stock to institutional investors at $6 per share yielding gross proceeds of ~$20M. Closing date is October 24.</li><li>Yesterday's close was $6.35.</li></ul><div class=\"tiny-share-widget\" data-id=\"3302215\" data-linked=\"Cidara prices private placement of shares at $6; shares up 2%\" data-tweet=\"$CDTX - Cidara prices private placement of shares at $6; shares up 2% https://seekingalpha.com/news/3302215-cidara-prices-private-placement-of-shares-6-shares-up-2?source=tweet\" data-url=\"https://seekingalpha.com/news/3302215-cidara-prices-private-placement-of-shares-6-shares-up-2\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:48 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3302212\" data-ts=\"1508420371\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SVU\" target=\"_blank\">SVU</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3302212-investors-size-up-supervalu\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Investors size up Supervalu</a></h4><ul> <li>Supervalu (NYSE:<a href='https://seekingalpha.com/symbol/SVU' title='SUPERVALU Inc.'>SVU</a>) is <font color='red'>down another 2.87%</font> to extend on yesterday's sharp sell-off after the company surprised with an unexpected wind-down of a transition services agreement with Albertson's.</li> <li>Despite the TSA surprise, analysts are issuing favorable comments on Supervalu following the grocery operator's strong earnings report. RBC Capital keeps an Outperform rating and boosts its price target to $42, while Pivotal Research calls valuation \"attractive\" on Supervalu.</li> <li><a href=\"https://seekingalpha.com/filing/3731499\" target=\"_blank\">SEC Form 10-Q </a></li><li>Previously: <a href=\"https://seekingalpha.com/news/3301726-supervalus-q2-results\" target=\"_blank\">More on Supervalu's Q2 results</a> (Oct. 18)</li><li>Previously: <a href=\"https://seekingalpha.com/news/3301825-supervalu-leads-grocery-sector-higher\" target=\"_blank\">Supervalu leads grocery sector higher</a> (Oct. 18)</li> </ul><div class=\"tiny-share-widget\" data-id=\"3302212\" data-linked=\"Investors size up Supervalu\" data-tweet=\"$SVU - Investors size up Supervalu https://seekingalpha.com/news/3302212-investors-size-up-supervalu?source=tweet\" data-url=\"https://seekingalpha.com/news/3302212-investors-size-up-supervalu\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:39 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>21&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3302210\" data-ts=\"1508420075\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ADBE\" target=\"_blank\">ADBE</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3302210-analysts-up-adobe-price-targets-after-analyst-day-sharesplus-9_4\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Analysts up Adobe price targets after analyst day; shares +9.4%</a></h4><ul><li>        Analysts up Adobe (NASDAQ:<a href='https://seekingalpha.com/symbol/ADBE' title='Adobe Systems Incorporated'>ADBE</a>) price targets following the yesterday&rsquo;s analyst day, which included a reiteration of the Q4 guidance.</li><li>               Cowen raises its Adobe price target from $165 to $185 and maintains an Outperform rating.&nbsp;</li><li>               Analyst Derrick Wood says, &ldquo;Surprise came from the resiliency of Digital Media growth&rdquo; and notes that price increases coming in March show the company &ldquo;flexing its market dominance.&rdquo;&nbsp;</li><li>               Jefferies analyst Brent Thill raises his price target by $10 to $190 with a Buy rating.&nbsp;</li><li>               Thill ups EPS estimates for FY18 from $5.15 to $5.50 and FY19 from $6.29 to $6.63.&nbsp;</li><li>               Piper Jaffary raises Adobe&rsquo;s price target from $180 to $195 with an Overweight rating.&nbsp;</li><li>               Analyst Alex Zukin says FY18 guidance implies operating margins over 40% and that doesn&rsquo;t include the price increases.&nbsp;</li><li>               Source: Bloomberg First Word&nbsp;</li><li>Adobe shares are&nbsp;<font color='green'>up 9.35%</font>.&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;</li></ul><div class=\"tiny-share-widget\" data-id=\"3302210\" data-linked=\"Analysts up Adobe price targets after analyst day; shares +9.4%\" data-tweet=\"$ADBE - Analysts up Adobe price targets after analyst day; shares +9.4% https://seekingalpha.com/news/3302210-analysts-up-adobe-price-targets-after-analyst-day-sharesplus-9_4?source=tweet\" data-url=\"https://seekingalpha.com/news/3302210-analysts-up-adobe-price-targets-after-analyst-day-sharesplus-9_4\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:34 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>12&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3302207\" data-ts=\"1508419757\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CEI\" target=\"_blank\">CEI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3302207-camber-energy-offers-strategic-plan-names-schleizer-full-time-cfo\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Camber Energy offers strategic plan, names Schleizer full-time CFO</a></h4><ul>     <li>Camber Energy (NYSEMKT:<a href='https://seekingalpha.com/symbol/CEI' title='Camber Energy, Inc.'>CEI</a>) <font color='green'>+19.3%</font> premarket after disclosing that its board <a href=\"https://seekingalpha.com/filing/3731287\" target=\"_blank\">removed the interim designation</a> for Robert Schleizer as its CFO.</li>     <li>CEI also says it expects to drill 8-10 new wells in 2018, subject to sufficient funding, which could collectively generate ~$1M/month in EBITDA by year-end 2018.</li>     <li>CEI says it submitted a formal plan to the NYSE calling for the company to regain compliance with NYSE listing standards no later than August 2018.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3302207\" data-linked=\"Camber Energy offers strategic plan, names Schleizer full-time CFO\" data-tweet=\"$CEI - Camber Energy offers strategic plan, names Schleizer full-time CFO https://seekingalpha.com/news/3302207-camber-energy-offers-strategic-plan-names-schleizer-full-time-cfo?source=tweet\" data-url=\"https://seekingalpha.com/news/3302207-camber-energy-offers-strategic-plan-names-schleizer-full-time-cfo\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:29 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3302206\" data-ts=\"1508419739\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ANGI\" target=\"_blank\">ANGI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3302206-angi-homeservicesplus-3_8-wells-fargo-boosts-to-outperform\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">ANGI Homeservices +3.8% as Wells Fargo boosts to Outperform</a></h4><ul>   <li>ANGI Homeservices (NASDAQ:<a href='https://seekingalpha.com/symbol/ANGI' title='ANGI Homeservices Inc.'>ANGI</a>) is <font color='green'>up 3.8%</font> premarket after Wells Fargo boosts its rating to Outperform.</li>    <li>The firm set a price target of $14, implying 16.3% upside.</li>    <li>The stock is <font color='red'>down 5.9%</font> since the Angie's List vote to combine with IAC/InterActiveCorp; shares are <font color='green'>up 46.3%</font> YTD.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3302206\" data-linked=\"ANGI Homeservices +3.8% as Wells Fargo boosts to Outperform\" data-tweet=\"$ANGI - ANGI Homeservices +3.8% as Wells Fargo boosts to Outperform https://seekingalpha.com/news/3302206-angi-homeservicesplus-3_8-wells-fargo-boosts-to-outperform?source=tweet\" data-url=\"https://seekingalpha.com/news/3302206-angi-homeservicesplus-3_8-wells-fargo-boosts-to-outperform\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:28 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3302203\" data-ts=\"1508419539\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ARCT\" target=\"_blank\">ARCT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3302203-alcobra-up-46-premarket-on-arcturus-janssen-deal-in-hbv\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Alcobra up 46% premarket on Arcturus/Janssen deal in HBV</a></h4><ul><li>Alcobra (ADHD) is up&nbsp;<font color='green'>46%&nbsp;</font>premarket on robust volume in response to merger partner Arcturus Therapeutics' collaboration and license <a href=\"https://seekingalpha.com/pr/16973260-arcturus-therapeutics-announces-strategic-collaboration-johnson-and-johnson-innovation\" target=\"_blank\">agreement</a> with Johnson &amp; Johnson (NYSE:<a href='https://seekingalpha.com/symbol/JNJ' title='Johnson & Johnson'>JNJ</a>) unit Janssen Pharmaceuticals aimed at developing and commercializing nucleic acid-based drugs for the treatment of hepatitis B virus &#40;HBV&#41; infection using Arcturus' UNA Oligomer chemistry and LUNAR lipid-mediated delivery platform.</li><li>Under the terms of the agreement, Arcturus will receive an upfront cash payment, R&amp;D support, milestones and royalties on net sales of commercialized products. Janssen will be responsible for development and commercialization costs.</li></ul><div class=\"tiny-share-widget\" data-id=\"3302203\" data-linked=\"Alcobra up 46% premarket on Arcturus/Janssen deal in HBV\" data-tweet=\"$ARCT $ARCT $JNJ - Alcobra up 46% premarket on Arcturus/Janssen deal in HBV https://seekingalpha.com/news/3302203-alcobra-up-46-premarket-on-arcturus-janssen-deal-in-hbv?source=tweet\" data-url=\"https://seekingalpha.com/news/3302203-alcobra-up-46-premarket-on-arcturus-janssen-deal-in-hbv\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:25 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3302201\" data-ts=\"1508419393\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3302201-premarket-gainers-of-9-05\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Premarket Gainers as of 9:05 am</a></h4><ul><li>ADHD <font color='green'>+41%.</font></li><li><a href='https://seekingalpha.com/symbol/QURE' title='uniQure N.V.'>QURE</a>&nbsp;<font color='green'>+36%.</font></li><li><a href='https://seekingalpha.com/symbol/RGSE' title='RGS Energy, Inc.'>RGSE</a>&nbsp;<font color='green'>+25%.</font></li><li><a href='https://seekingalpha.com/symbol/RWLK' title='ReWalk Robotics'>RWLK</a>&nbsp;<font color='green'>+24%.</font></li><li><a href='https://seekingalpha.com/symbol/CRBP' title='Corbus Pharmaceuticals Holdings, Inc.'>CRBP</a>&nbsp;<font color='green'>+23%.</font></li><li><a href='https://seekingalpha.com/symbol/BLFS' title='BioLife Solutions, Inc.'>BLFS</a>&nbsp;<font color='green'>+15%.</font></li><li><a href='https://seekingalpha.com/symbol/ONCS' title='OncoSec Medical Incorporated'>ONCS</a>&nbsp;<font color='green'>+13%.</font></li><li><a href='https://seekingalpha.com/symbol/LLNW' title='Limelight Networks, Inc.'>LLNW</a>&nbsp;<font color='green'>+11%.</font></li><li><a href='https://seekingalpha.com/symbol/ADBE' title='Adobe Systems Incorporated'>ADBE</a>&nbsp;<font color='green'>+9%.</font></li><li><a href='https://seekingalpha.com/symbol/GNMX' title='Aevi Genomic Medicine, Inc.'>GNMX</a>&nbsp;<font color='green'>+7%.</font></li><li><a href='https://seekingalpha.com/symbol/PSTI' title='Pluristem Therapeutics, Inc.'>PSTI</a>&nbsp;<font color='green'>+6%.</font></li></ul><div class=\"tiny-share-widget\" data-id=\"3302201\" data-linked=\"Premarket Gainers as of 9:05 am\" data-tweet=\"$ARCT $QURE $RGSE - Premarket Gainers as of 9:05 am https://seekingalpha.com/news/3302201-premarket-gainers-of-9-05?source=tweet\" data-url=\"https://seekingalpha.com/news/3302201-premarket-gainers-of-9-05\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:23 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>6&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3302202\" data-ts=\"1508419393\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/VZ\" target=\"_blank\">VZ</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3302202-verizonplus-2_8-subscribers-revenues-surprise-to-upside\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Verizon +2.8% as subscribers, revenues surprise to upside</a></h4><ul>   <li>Verizon (NYSE:<a href='https://seekingalpha.com/symbol/VZ' title='Verizon Communications'>VZ</a>) is <font color='green'>up 2.8%</font> premarket after a healthy revenue beat and another gain of wireless subscribers that surpassed expectations in its <a href=\"https://seekingalpha.com/news/3302131-verizon-eps-line-beats-revenue\" target=\"_blank\">Q3 earnings</a>.</li>    <li>It added 603,000 net retail postpaid subs, 486,000 of which were postpaid smartphone net adds. Net phone additions were 274,000; tablet net adds were 91,000 and net adds of other devices, led by wearables, was 238,000.</li>    <li>Retail postpaid churn was at 0.97% and retail postpaid phone churn low again at 0.75%.</li>    <li>Meanwhile, FiOS revenues were up 4.8%; consumer FiOS revenues were up 4.6%.</li>    <li>EPS was flat on a headline basis and fell slightly on a non-GAAP basis, to $0.98 from $1.01. Revenues that grew 2.5% were down 2.3% on a comparable basis (excluding divestitures/acquisitions).</li>    <li>Revenue breakout: Service and other, $27.4B (up 2.1%); Wireless equipment, $4.35B (up 5.5%).</li>    <li>Integrating AOL and Yahoo is \"ahead of internal expectations,\" and Oath revenues were $2B.</li>    <li>Cash flow from operations was $17.2B for the first nine months; YTD capex came to $11.3B.</li>    <li>For the full year it expects organic revenues consistent with last year (and similar trends in EPS), with improvement in wireless service revenue and equipment revenue trends. Consolidated capital spending is expected at the lower end of a range of $16.8B-$17.5B, and it sees 2017 effective tax around 34%.</li>    <li><a href=\"https://seekingalpha.com/pr/16973329-verizon-builds-2q-momentum-strong-3q-results\" target=\"_blank\">Press Release</a></li> </ul><div class=\"tiny-share-widget\" data-id=\"3302202\" data-linked=\"Verizon +2.8% as subscribers, revenues surprise to upside\" data-tweet=\"$VZ - Verizon +2.8% as subscribers, revenues surprise to upside https://seekingalpha.com/news/3302202-verizonplus-2_8-subscribers-revenues-surprise-to-upside?source=tweet\" data-url=\"https://seekingalpha.com/news/3302202-verizonplus-2_8-subscribers-revenues-surprise-to-upside\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:23 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>7&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3302198\" data-ts=\"1508419069\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/IMNP\" target=\"_blank\">IMNP</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3302198-immune-pharma-prices-equity-offering-shares-down-7-premarket\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Immune Pharma prices equity offering; shares down 7% premarket</a></h4><ul><li>Nano cap Immune Pharmaceuticals (<a href='https://seekingalpha.com/symbol/IMNP' title='Immune Pharmaceuticals Inc.'>OTCQB:IMNP</a>) is down&nbsp;<font color='red'>7%</font>&nbsp;premarket on light volume in response to the <a href=\"https://seekingalpha.com/pr/16973687-immune-pharmaceuticals-inc-announces-pricing-18000-000-public-offering-convertible-preferred\" target=\"_blank\">pricing </a>of its public offering of 18K Units at $1,000 per Unit.</li><li>Each Unit consists of one share of Series E Convertible Preferred Stock and 982 seven-year warrants, each eligible to purchase one share of common stock at $1.10.</li><li>Each Series E share is convertible into common shares by dividing $1,080 (the stated value) by the conversion price, $1.10 for the first 40 days after the offering closes and the lesser of $1.10 and 87.5% of the lowest volume-weighted average price of the common stock during the five days prior to the date of the notice of conversion, subject to adjustments, thereafter.</li><li>Closing date is October 23.</li><li>Yesterday's close was $1.51.</li></ul><div class=\"tiny-share-widget\" data-id=\"3302198\" data-linked=\"Immune Pharma prices equity offering; shares down 7% premarket\" data-tweet=\"$IMNP $IMNPQ - Immune Pharma prices equity offering; shares down 7% premarket https://seekingalpha.com/news/3302198-immune-pharma-prices-equity-offering-shares-down-7-premarket?source=tweet\" data-url=\"https://seekingalpha.com/news/3302198-immune-pharma-prices-equity-offering-shares-down-7-premarket\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:17 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3302191\" data-ts=\"1508418171\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/VIVO\" target=\"_blank\">VIVO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3302191-meridian-bio-sees-eps-up-to-0_51-in-fiscal-2017-shares-ahead-8-premarket\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Meridian Bio sees EPS up to $0.51 in fiscal 2017; shares ahead 8% premarket</a></h4><ul><li>Thinly traded Meridian Bioscience (NASDAQ:<a href='https://seekingalpha.com/symbol/VIVO' title='Meridian Bioscience Inc.'>VIVO</a>) is up&nbsp;<font color='green'>8%&nbsp;</font>premarket on light volume in response to its <a href=\"https://seekingalpha.com/pr/16973323-meridian-bioscience-inc-comments-preliminary-fiscal-2017-operating-results-provides-fiscal\" target=\"_blank\">preliminary fiscal 2017 results</a> (ended September 30). It expects revenues of ~$200.5M (+2%) and EPS of $0.50 - 0.51. Non-GAAP EPS should be $0.66 -0.67.</li><li>Fiscal Q4 revenue is expected to be ~$49.5M (+5%).</li><li><strong>Fiscal 2018 guidance</strong>: Revenues: $207M - 212M; EPS: $0.59 - 0.62; Non-GAAP EPS: $0.65 - 0.68.</li></ul><div class=\"tiny-share-widget\" data-id=\"3302191\" data-linked=\"Meridian Bio sees EPS up to $0.51 in fiscal 2017; shares ahead 8% premarket\" data-tweet=\"$VIVO - Meridian Bio sees EPS up to $0.51 in fiscal 2017; shares ahead 8% premarket https://seekingalpha.com/news/3302191-meridian-bio-sees-eps-up-to-0_51-in-fiscal-2017-shares-ahead-8-premarket?source=tweet\" data-url=\"https://seekingalpha.com/news/3302191-meridian-bio-sees-eps-up-to-0_51-in-fiscal-2017-shares-ahead-8-premarket\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:02 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3302182\" data-ts=\"1508417334\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ONCS\" target=\"_blank\">ONCS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3302182-oncosecs-immunopulse-ilminus-12-shows-treatment-benefit-in-mid-stage-melanoma-studies-shares\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">OncoSec&#39;s ImmunoPulse IL-12 shows treatment benefit in mid-stage melanoma studies; shares ahead 12% premarket</a></h4><ul><li>Thinly traded nano cap OncoSec Medical (NASDAQ:<a href='https://seekingalpha.com/symbol/ONCS' title='OncoSec Medical Incorporated'>ONCS</a>) is up&nbsp;<font color='green'>12%</font>&nbsp;premarket on robust volume in response to its <a href=\"https://seekingalpha.com/pr/16973187-oncosec-presents-positive-phase-2-data-immunopulse-ilminus-12-combination-pembrolizumab\" target=\"_blank\">announcement </a>of positive results from two Phase 2 clinical trials assessing ImmunoPulse IL-12 in patients with treatment-resistant melanoma. The data were presented today at the 9th World Congress of Melanoma in Brisbane, Australia.</li><li>One study, OMS-I102, evaluated the combination of ImmunoPulse and Merck's KEYTRUDA (pembrolizumab) in 22 melanoma patients who were not predicted to respond to the PD-1 inhibitor on the basis of biomarker data. The best overall response rate &#40;BORR&#41; was 50% (n=11/22), including nine complete responders and and two partial responders. The disease control rate was 59% (n=13/22), which included two subjects with stable disease.</li><li>The other study, OMS-I100, evaluated ImmunoPulse as monotherapy on a 90-day cycle. The BORR was 34.6% (n=9/26), including five complete responders and four partial responders. The disease control rate was 69.2% (n=18/26) which included nine subjects with stable disease. In a protocol addendum, twenty patients were treated with ImmunoPulse on a six-week cycle. There were no complete responders but the disease control rate was 65%.</li><li>Initial data from the PISCES/KEYNOTE-695 study should be available in mid-2018.</li></ul><div class=\"tiny-share-widget\" data-id=\"3302182\" data-linked=\"OncoSec&#39;s ImmunoPulse IL-12 shows treatment benefit in mid-stage melanoma studies; shares ahead 12% premarket\" data-tweet=\"$ONCS - OncoSec&#39;s ImmunoPulse IL-12 shows treatment benefit in mid-stage melanoma studies; shares ahead 12% premarket https://seekingalpha.com/news/3302182-oncosecs-immunopulse-ilminus-12-shows-treatment-benefit-in-mid-stage-melanoma-studies-shares?source=tweet\" data-url=\"https://seekingalpha.com/news/3302182-oncosecs-immunopulse-ilminus-12-shows-treatment-benefit-in-mid-stage-melanoma-studies-shares\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:48 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>25&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li>","count":75,"message":null,"success":true,"today":{"start":1577077200,"end":1577163599,"str":"Monday, December 23, 2019"},"yesterday":{"start":1576990800,"end":1577077199}}